<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.2 20190208//EN" "JATS-archivearticle1-mathml3.dtd"> 
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="review-article"><?properties open_access?><?DTDIdentifier.IdentifierValue -//NLM//DTD Journal Publishing DTD v2.3 20070202//EN?><?DTDIdentifier.IdentifierType public?><?SourceDTD.DTDName journalpublishing.dtd?><?SourceDTD.Version 2.3?><?ConverterInfo.XSLTName jp2nlmx2.xsl?><?ConverterInfo.Version 1?><front><journal-meta><journal-id journal-id-type="nlm-ta">Arch Acad Emerg Med</journal-id><journal-id journal-id-type="iso-abbrev">Arch Acad Emerg Med</journal-id><journal-id journal-id-type="publisher-id">AAEM</journal-id><journal-title-group><journal-title>Archives of Academic Emergency Medicine</journal-title></journal-title-group><issn pub-type="epub">2645-4904</issn><publisher><publisher-name>Shahid Beheshti University of Medical Sciences</publisher-name><publisher-loc>Tehran, Iran</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">7587986</article-id><article-id pub-id-type="publisher-id">aaem-8-e74</article-id><article-categories><subj-group subj-group-type="heading"><subject>Review Article</subject></subj-group></article-categories><title-group><article-title>The Potential Role of Super Spread Events in SARS-COV-2 Pandemic; a Narrative Review</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Kyriakopoulos</surname><given-names>Anthony M.</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="corresp" rid="cor1">*</xref></contrib><contrib contrib-type="author"><name><surname>Papaefthymiou</surname><given-names>Apostolis</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="aff" rid="aff3">3</xref></contrib><contrib contrib-type="author"><name><surname>Georgilas</surname><given-names>Nikolaos</given-names></name><xref ref-type="aff" rid="aff4">4</xref></contrib><contrib contrib-type="author"><name><surname>Doulberis</surname><given-names>Michael</given-names></name><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="aff" rid="aff5">5</xref></contrib><contrib contrib-type="author"><name><surname>Kountouras</surname><given-names>Jannis</given-names></name><xref ref-type="aff" rid="aff3">3</xref></contrib></contrib-group><aff id="aff1">
<label>1</label>Department of Research and Development, Nasco AD Biotechnology Laboratory, Piraeus 18536, Greece. </aff><aff id="aff2">
<label>2</label>Department of Gastroenterology, University Hospital of Larisa, Larisa 41110, Greece.</aff><aff id="aff3">
<label>3</label>Department of Internal Medicine, Second Medical Clinic, Ippokration Hospital, Aristotle University of Thessaloniki, Thessaloniki, 54642 Macedonia, Greece.</aff><aff id="aff4">
<label>4</label>Department of Nephrology, Agios Pavlos Hospital of Thessaloniki, Thessaloniki 55134, Macedonia, Greece.</aff><aff id="aff5">
<label>5</label>Division of Gastroenterology and Hepatology, University Medical Department Kantonsspital Aarau, Aarau 5001, Switzerland.</aff><author-notes><corresp id="cor1"><label>*</label>Corresponding author: Anthony M. Kyriakopoulos; Department of Research and Development, Nasco AD Biotechnology Laboratory, 11 Sachtouri Str, Piraeus 18536, Greece. Email: antkyriak@gmail.com, Fax : 00309210818032</corresp></author-notes><pub-date pub-type="collection"><year>2020</year></pub-date><pub-date pub-type="epub"><day>21</day><month>9</month><year>2020</year></pub-date><volume>8</volume><issue>1</issue><elocation-id>e74</elocation-id><history><date date-type="received"><month>8</month><year>2020</year></date><date date-type="accepted"><month>8</month><year>2020</year></date></history><permissions><license license-type="open-access"><license-p>This is an Open Access article distributed under the terms of the Creative Commons Attribution License, (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/3.0/">http://creativecommons.org/licenses/by/3.0/</ext-link>) which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p></license></permissions><abstract><p>Coronaviruses, members of <italic>Coronaviridae</italic> family, cause extensive epidemics of vast diseases like severe acute respiratory syndrome (SARS) and Coronavirus Disease-19 (COVID-19) in animals and humans. Super spread events (SSEs) potentiate early outbreak of the disease and its constant spread in later stages. Viral recombination events within species and across hosts lead to natural selection based on advanced infectivity and resistance. In this review, the importance of containment of SSEs was investigated with emphasis on stopping COVID-19 spread and its socio-economic consequences. A comprehensive search was conducted among literature available in multiple electronic sources to find articles that addressed the &#x0201c;potential role of SSEs on severe acute respiratory syndrome coronavirus 2 (SARS-COV-2) pandemic&#x0201d; and were published before 20<sup>th</sup> of August 2020. Overall, ninety-eight articles were found eligible and reviewed. Specific screening strategies within potential super spreading host groups can also help to efficiently manage severe acute respiratory syndrome coronavirus 2 (SARS-COV-2) epidemics, in contrast to the partially effective general restriction measures. The effect of SSEs on previous SARS epidemics has been documented in detail. However, the respective potential impact of SSEs on SARS-COV-2 outbreak is composed and presented in the current review, thereby implying the warranted effort required for effective SSE preventive strategies, which may lead to overt global community health benefits. This is crucial for SARS-COV-2 pandemic containment as the vaccine(s) development process will take considerable time to safely establish its potential usefulness for future clinical usage. </p></abstract><kwd-group><title>Key Words</title><kwd>Pandemics</kwd><kwd>epidemics</kwd><kwd>coronavirus</kwd><kwd>severe acute respiratory syndrome coronavirus 2</kwd><kwd>disease outbreaks</kwd><kwd>cost of illness</kwd><kwd>mass vaccination</kwd></kwd-group></article-meta></front><body><sec sec-type="intro"><title>Introduction</title><p>Severe acute respiratory syndrome (SARS) has periodically emerged as epidemics and its natural history could be utilized as a &#x0201c;compass&#x0201d; to comprehend and manage the current pandemic of SARS-COV-2. SARS-COV-2 the etiologic agent of the novel coronavirus disease 2019 (COVID-19), belongs to RNA coronavirus family (<italic>Coronaviridae</italic>) and is a zoonotic coronavirus that has crossed species barriers to infect human (<xref rid="B1" ref-type="bibr">1</xref>-<xref rid="B3" ref-type="bibr">3</xref>). The initially investigated strains of COVID-19 exhibited low potential for transmissibility and infectivity, similar to SARS coronavirus (SARS-COV) (<xref rid="B1" ref-type="bibr">1</xref>-<xref rid="B4" ref-type="bibr">4</xref>). Moreover, SARS epidemic was potentiated due to super spread events (SSEs), which led to unexpected elevation of the basic reproduction numbers as calculated via associated epidemiology equations (<xref rid="B5" ref-type="bibr">5</xref>). Specifically, SSEs resulted from secondary contacts of carriers (<xref rid="B6" ref-type="bibr">6</xref>, <xref rid="B7" ref-type="bibr">7</xref>). Infected individuals, as mediators of SSEs, represent the initial cluster of viral transmission (<xref rid="B8" ref-type="bibr">8</xref>); thus, inducing an exponential secondary contamination (<xref rid="B4" ref-type="bibr">4</xref>). Although the prediction and subsequently the prevention of SSEs seems to be complicated, the virus, host, environmental, and mass behaviors determine relative approaches to prevent and control SSEs; core community health programs can inhibit and decrease the incidence and the effect of&#x000a0;SSEs (<xref rid="B9" ref-type="bibr">9</xref>). Nevertheless, horizontal austerity measures, such as recommending or compelling individuals to self-isolate at home, which might cause serious social and psychological burden, and quarantine, also leading to loss of income due to social distancing,&#x000a0;are associated with negative psychological and religious effects, which can be long lasting (<xref rid="B10" ref-type="bibr">10</xref>), thereby leading to serious instability of the global society. Prolonged social isolation and loneliness are associated with increased mortality (<xref rid="B11" ref-type="bibr">11</xref>). </p><p>Currently, limited piece of information exists regarding the effect of SSEs on coronavirus epidemics. The aim of this narrative review is to mainly focus on the potential impact of SSEs on large outbreaks of coronavirus. The development of an emergency SARS-COV-2 vaccine has its potential usefulness and/or limitations and may result in severe health outcomes, which prompts better screening for SSEs in order to control coronavirus pandemics. </p></sec><sec sec-type="methods"><title>Methods</title><p>
<bold>2.1 Methodological approach </bold>
</p><p>To avoid, in most respects, literature selection bias (<xref rid="B12" ref-type="bibr">12</xref>), multiple electronic sources: Medline/PubMed, SciFinder, Science Direct and Goggle Scholar as well as ResearchGate and General (Google) were investigated via queries with a non-restricted time frame reaching the 20<sup>th</sup> of August 2020. Initial investigation of SSEs and SARS, SSEs and MERS, and SSEs and COVID-19, gave narrative results from PubMed. The selected literature, which is included in the study, is presented in <xref rid="T1" ref-type="table">table 1</xref>. Same items were also searched in all other mentioned sources. The scope of the study was not only to investigate the transmission of SARS-COV-2 due to SSEs, its comparison with SARS-COV-1 and MERS-COV, but also to assess the general global impact due to SSEs by COVID-19. Therefore, further literature investigation was performed using the same electronic sources. Further investigation was made on: a) the prevention of SSEs by coronaviruses causing SAR-1, MERS and COVID-19, b) the socio-economic relation of SARS-COV-1, MERS and COVID-19 due to SSEs, c) the austerity caused by SSEs of COVID-19, and d) the relation of SSEs containment to future vaccination programs. For further investigation, the following items were searched: &#x0201c;SARS, MERS and COVID-19 Epidemic Prevention&#x0201d;, &#x0201c;SARS MERS and COVID-19 Infectivity and Pathogenicity&#x0201d;, &#x0201c;Coronavirus SSE Prevention&#x0201d;, SSE Coronavirus Crisis and Socio-economics&#x0201d;, &#x0201c;Holy Cup Religion and Transmission of Pathogens and SSEs&#x0201d;, and &#x0201c;Coronavirus Immunity and Vaccination&#x0201d;. </p><p>
<bold>2.2 Selection process</bold>
</p><p>
<bold>2.2.1 Screening Process and Eligibility Criteria</bold>
</p><p>Studies providing an adequate determination of an SSE related to SARS, MERS and COVID-19 were primarily screened and selected by two reviewers (authors) blinded to one another. The results were thereafter cross-matched and duplicates were removed. Based on this primary search, the socio-economic impact of coronavirus, produced by SSEs, was extrapolated by two other reviewers (authors). Following this initial selection stage, further screening was performed by all reviewers, using the previously described search items to identify parameters determining the global impact of COVID-19 due to SSEs. Identified parameters included the global impact of immunity and vaccination, the holy cup and religion transmission, and the austerity caused by COVID-19 and other coronavirus epidemics due to restrictions applied. All search results were cross-matched to remove duplicates and thereafter, exclusion and inclusion criteria were applied. </p><p>
<bold>2.2.2 Exclusion and Inclusion Criteria</bold>
</p><p>After removing the duplicates, review was conducted on titles and abstracts. Also, a decision was made to remove &#x0201c;news press opinions&#x0201d;. Computational model methodologies producing contradictory results, studies with wrong interpretation of SSEs, and studies with non-clear-cut results were also removed. Studies using the interpretation &#x0201c;a super spreading individual, known as the index case, produces a cluster of SARS, MERS, and COVID-19 secondary infections&#x0201d; were included. A second exclusion criterion was applied. In this stage, peer reviewed literature of recent dates, studies assessing SARS, MERS, and COVID-19 epidemiology measures, studies on COVID-19 restriction measures producing social and economic austerity, articles discussing the perspective for future vaccination and population immunity, and finally genetic studies on coronaviruses causing SARS, MERS, and COVID-19. </p></sec><sec sec-type="results"><title>Results</title><p>By following the described methodology, on Medline/PubMed: a) 23 articles were found on SARS and MERS and SSE, and b) 11 articles were found on COVID-19 and SSEs. Out of: a) 13 of the 23 articles on SARS and MERS and SSE, and b) 7 out of the 11 articles on COVID-19 and SSE were deemed relevant hits. After applying the exclusion criteria, 12 articles from the first category, and 4 from the second category were included in the study. Suitable articles found by searching, which were selected and reviewed for each part, are illustrated in <xref ref-type="fig" rid="F1">figure 1</xref>. Further investigation in all other electronic sources described, using the same methodology, increased the number of the included literature to a) 17 and b) 14, for their respective categories of search. Studies included from PubMed in these categories of searches are briefly described and listed in <xref rid="T1" ref-type="table">table 1</xref>. Further, assessing the general global impact of SSEs related to COVID-19, using all the mentioned sources, via the same methodology, led to the inclusion of a) 10 articles related to genetic analysis of SARS-COV-1 and MERS-COV and SARS-COV-2, b) 5 articles related to super spread events, c) 2 articles related to austerity, d) 18 articles related to infectivity and pathogenicity of SARS, MERS and COVID-19, e) 17 articles related to prevention of SSEs concerning human coronaviruses, f) 9 articles related to socio-economic impact, and g) 9 articles related to immunity and future vaccination. <xref rid="T2" ref-type="table">Table 2</xref> illustrates the initial numbers of hits using all search items in all sources, and the final number of articles reviewed in each category. </p></sec><sec sec-type="discussion"><title>Discussion</title><p>
<bold>4.1 Insights to SSEs</bold>
</p><p>The involvement of SSEs in SARS extensive outbreaks (<xref rid="B1" ref-type="bibr">1</xref>, <xref rid="B4" ref-type="bibr">4</xref>, <xref rid="B5" ref-type="bibr">5</xref>, <xref rid="B13" ref-type="bibr">13</xref>-<xref rid="B17" ref-type="bibr">17</xref>), necessitates urgent elucidation as global tranquility is disturbed by COVID-19 pandemic. Epidemiological research has proposed that the outbreak was related to a seafood market in Wuhan (Hubei, China), underlining the ongoing risk of viral transmission from animals to induce severe diseases in humans. Metagenomic RNA sequencing of bronchoalveolar lavage fluid from a patient with pneumonia identified a novel RNA virus strain from the Coronaviridae family&#x000a0; (called SARS-COV-2); and phylogenetic analysis (by introducing the widely used <italic>in silico</italic> protein screening) (<xref rid="B18" ref-type="bibr">18</xref>-<xref rid="B21" ref-type="bibr">21</xref>) of the complete viral genome (29,903&#x000a0;nucleotides) disclosed that the virus was most closely connected (89.1% nucleotide similarity) with a group of SARS-like coronaviruses (genus <italic>Betacoronavirus</italic>, subgenus <italic>Sarbecovirus</italic>) formerly isolated from bats in China (<xref rid="B18" ref-type="bibr">18</xref>-<xref rid="B22" ref-type="bibr">22</xref>).</p><p>Insights from previous reports by Menachery et al. (<xref rid="B23" ref-type="bibr">23</xref>) (Menachery <italic>et al.</italic>, 2015), pointed out that the 2002-2003 emergence of SARS-CoV introduced the possibility of viruses of animal origin causing epidemics in human populations. Conclusions from their study revealed, as previous studies had demonstrated (<xref rid="B1" ref-type="bibr">1</xref>, <xref rid="B5" ref-type="bibr">5</xref>, <xref rid="B13" ref-type="bibr">13</xref>, <xref rid="B15" ref-type="bibr">15</xref>), that closely related SARS-like viral genes were traceable in Chinese bat populations. Authors claimed that these viruses were capable of infecting humans, by selective adaptations or adjustments, and thereby, causing a new epidemic (<xref rid="B23" ref-type="bibr">23</xref>). Enhancement of virulence is also attributed to these adaptations due to acquisition of spike protein via adaptive mutations (<xref rid="B24" ref-type="bibr">24</xref>). </p><p>Continuous viral random mutations are possible through intermediate host transmission, until a deadly virus develops, as illustrated in <xref ref-type="fig" rid="F2">Figure 2</xref>. Recent evidence revealed that recombination within intermediate hosts has contributed to development of SARS-COV-2 (<xref rid="B1" ref-type="bibr">1</xref>, <xref rid="B24" ref-type="bibr">24</xref>). Asian outdoor markets could constitute the ideal places for continuous viral mutation exchanges (<xref rid="B25" ref-type="bibr">25</xref>). As presented in <xref rid="T3" ref-type="table">Table 3</xref>, the best way to circumvent continuous virus production is targeted surveillance; to at least stop the overspreading by SSEs (<xref rid="B2" ref-type="bibr">2</xref>, <xref rid="B3" ref-type="bibr">3</xref>, <xref rid="B22" ref-type="bibr">22</xref>, <xref rid="B26" ref-type="bibr">26</xref>). This has also been proposed by Menachery et al. (<xref rid="B23" ref-type="bibr">23</xref>).</p><p>
<bold>4.2 SARS epidemics and SARS-COV-2 pandemic</bold>
</p><p>SARS-COV-2 is accountable for the unprecedented COVID-19 pandemic (<xref rid="B27" ref-type="bibr">27</xref>), and the interplaying mechanisms involved in the pathophysiology of COVID-19 include SARS-COV-2 virulence, host immune response, and complex inflammatory reactions (<xref rid="B28" ref-type="bibr">28</xref>). Emerging data, also, imply that the reservoirs of SARS-COV-1 infection may be similar to COVID-19 (<xref rid="B1" ref-type="bibr">1</xref>, <xref rid="B4" ref-type="bibr">4</xref>, <xref rid="B5" ref-type="bibr">5</xref>, <xref rid="B13" ref-type="bibr">13</xref>, <xref rid="B29" ref-type="bibr">29</xref>), as remarkable similarities exist between SARS and swine acute diarrhea syndrome (SADS)&#x000a0;in topographical, temporal, environmental and etiological backgrounds. However, the increasing coronavirus variety and spread in bats were recognized as a potential target to diminish future epidemics that might impend livestock, community health, and financial progress (<xref rid="B30" ref-type="bibr">30</xref>). Probably, identification of animal and insect vectors that transmit the disease, identification and control of alternative routes of transmission like fecal-oral route, and identification of super spreader patient groups could help minimize the epidemiological extent compared to the one observed for SARS-COV-2 infection worldwide. Lessons from SARS epidemic taught us that the key to control is minimizing the time from the diagnosis of infection to prompt hospital isolation and diminishing the probability of another SSE (<xref rid="B5" ref-type="bibr">5</xref>).</p><p>
<bold>4.3 The 20/80 rule as applied to SARS</bold>
</p><p>The typically recognized 20&#x02013;80 rule or the so-called &#x0201c;Pareto rule&#x0201d;, states that 20% of efforts lead to 80% of results (<xref rid="B31" ref-type="bibr">31</xref>). More specifically, this comprises a principally convenient state when tackling infectious diseases and is applied to investigate infection transmission, and initially among cattle farms. In this regard, Woolhouse et al. (<xref rid="B17" ref-type="bibr">17</xref>) reported that targeted actions concerning disease control and prevention in 20% of the farms that mainly supplied the basic reproduction number (R<sub>o</sub>) decreased spread by 80% (<xref rid="B32" ref-type="bibr">32</xref>). Focusing on the COVID-19 virus, R<sub>o</sub>&#x000a0;is a sign of virus transmissibility, denoting the average figure of novel infections caused by an infectious individual in a totally na&#x000ef;ve population. For&#x000a0;<italic>R</italic><sub>0 </sub>&#x0003e; 1, the number of infected people tends to increase, whereas for&#x000a0;<italic>R</italic><sub>0 </sub>&#x0003c; 1, transmission is likely to stop; R<sub>o</sub> represents a chief model in the epidemics, signifying the risk of an infectious mediator with regard to epidemic spread (<xref rid="B33" ref-type="bibr">33</xref>). Recent data indicate that the estimated mean&#x000a0;R<sub>o</sub>&#x000a0;for COVID-19 is almost 3.28, with a median of 2.79 and the interquartile range (IQR) of 1.16, which is substantially higher than WHO&#x02019;s estimation of 1.95. However, due to biased methodology, R<sub>o</sub>&#x000a0;for COVID-19 is expected to be about 2&#x02013;3, which is approximately consistent with the WHO estimate (<xref rid="B33" ref-type="bibr">33</xref>). SSEs appear to be a main limitation of the R<sub>o</sub> concept. R<sub>o</sub>, when calculated as a mean or median value, does not include the heterogeneity of transmission between infected individuals (<xref rid="B4" ref-type="bibr">4</xref>); two infective agents with equal R<sub>0</sub>&#x000a0;estimates might have noticeably diverse patterns of transmission. Moreover, the goal of a Health Care System is to achieve R<sub>o</sub> &#x0003c;1, which is probably only phenomenally feasible in certain conditions without scheduled prevention, recognition, and response to SSEs (<xref rid="B9" ref-type="bibr">9</xref>). Naturally, epidemics follow the aforementioned 20 / 80 rule (<xref rid="B17" ref-type="bibr">17</xref>). Specifically, in human population, due to heterogeneous exposure to infectious agent, the 20% core population may transmit the disease, widely. For SARS, the rate might have been even lower than 20% (<xref rid="B4" ref-type="bibr">4</xref>). The increased infectious potential of a small population subgroup seems to be related to immunodeficiency, such as in hemodialysis, cancer, immunosuppressive therapies (<xref rid="B4" ref-type="bibr">4</xref>, <xref rid="B5" ref-type="bibr">5</xref>, <xref rid="B15" ref-type="bibr">15</xref>, <xref rid="B34" ref-type="bibr">34</xref>). Additionally, facilitation of disease spread and transmission due to vector exposure has been investigated in relation to cockroaches (<xref rid="B35" ref-type="bibr">35</xref>). Possible mechanical transportation by rats and cat (<xref rid="B13" ref-type="bibr">13</xref>, <xref rid="B36" ref-type="bibr">36</xref>) and air transmission (<xref rid="B37" ref-type="bibr">37</xref>) in SARS-COV-1 have also been studied. Other animals capable of being SARS-COV-2 carriers (excluding mice and rats), like pigs, ferrets, cats, and non-human primates have recently been introduced (<xref rid="B3" ref-type="bibr">3</xref>), and contamination of sewage with SARS-COV-2, has probably preceded COVID-19 outbreak in France (<xref rid="B29" ref-type="bibr">29</xref>). All these agents may contribute to a minimum of 80% of the total transmission potential (<xref rid="B17" ref-type="bibr">17</xref>), maybe even more (<xref rid="B4" ref-type="bibr">4</xref>, <xref rid="B5" ref-type="bibr">5</xref>). <xref rid="T4" ref-type="table">Table 4</xref> displays possible super spreader groups; thus, indicating screening targets to prevent SSEs. SARS epidemic taught us that control programs were inefficient in controlling the epidemic within a population, and failed to identify and provide a targeted infection diagnosis in groups causing potential SSEs (<xref rid="B5" ref-type="bibr">5</xref>, <xref rid="B17" ref-type="bibr">17</xref>). On the other hand, SARS-COV-2 having the ability to cause a pandemic rather than an epidemic, resulted in an increased number of cases and deaths; albeit having a lower mortality rate than SARS coronavirus (<xref rid="B2" ref-type="bibr">2</xref>). SSEs during COVID-19 may involve not only one city, but also a whole country or many countries, requiring investigation of their effects on a national or international level (<xref rid="B2" ref-type="bibr">2</xref>, <xref rid="B38" ref-type="bibr">38</xref>, <xref rid="B39" ref-type="bibr">39</xref>). </p><p>
<bold>4.4 Prevention of SSEs</bold>
</p><p>Preventing and decreasing COVID-19-related SSEs&#x000a0;necessitates the decryption of the mechanism through which SARS-COV-2 spreads through super spreader individuals, for example within healthcare facilities (<xref rid="B7" ref-type="bibr">7</xref>, <xref rid="B9" ref-type="bibr">9</xref>). Healthcare facilities are essential for prevention and control of SSEs (<xref rid="B9" ref-type="bibr">9</xref>). SSE prevention may enable us to even overcome initial low COVID-19 virus infectiveness. The capability of the virus to produce SSEs troubles the epidemiological attempts to restrict viral spread only by isolating individuals at high risk and performing obsolete isolation at home for the general population as carried out in countries such as Greece (<xref rid="B5" ref-type="bibr">5</xref>). During the SARS epidemic in China (Beijing) and Singapore, the vast majority of infected individuals were barely infective and only 6% of the population was highly infectious, in contrast to many published SARS models (<xref rid="B4" ref-type="bibr">4</xref>, <xref rid="B5" ref-type="bibr">5</xref>). Other ways of potential coronavirus transmission between hosts may provide explanations for enormous outbreaks (<xref rid="B16" ref-type="bibr">16</xref>). It should not be disregarded that coronaviruses cause both respiratory and intestinal infections and share common evolutionary roots with hepatitis viruses (<xref rid="B40" ref-type="bibr">40</xref>, <xref rid="B41" ref-type="bibr">41</xref>). Passing the cross-species barrier and genetic adaptation within hosts may promote virulence of coronaviruses in humans (<xref rid="B14" ref-type="bibr">14</xref>). This, prompts to specifically identify potential super spreader groups within populations through targeted diagnosis. Some of these groups are listed in <xref rid="T2" ref-type="table">Table 2</xref>. For this purpose, a usual infection must be distinguished from a super spread infection (<xref rid="B4" ref-type="bibr">4</xref>, <xref rid="B5" ref-type="bibr">5</xref>). During SARS epidemic, the coronavirus infectiousness mostly occurred in the late stages of infection (<xref rid="B5" ref-type="bibr">5</xref>, <xref rid="B17" ref-type="bibr">17</xref>), whereas in COVID-19, viruses are transmitted even in pre-symptomatic stages (<xref rid="B42" ref-type="bibr">42</xref>). As with Influenza A virus subtype H1N1 transmission (<xref rid="B43" ref-type="bibr">43</xref>), accurate diagnosis of COVID-19 in potentially asymptomatic super spreaders may help contain the magnitude of large outbreaks (<xref rid="B44" ref-type="bibr">44</xref>). </p><p>In the case of Diamond Princess Cruise ship, an early-assessed R<sub>0</sub>&#x000a0;of 14.8 (&#x02248;4 times higher than the R<sub>0</sub>&#x000a0;in the epicenter of the outbreak in Wuhan, China) was decreased to an assessed effective R<sub>o</sub> of 1.78 following on-board isolation and quarantine processes (<xref rid="B45" ref-type="bibr">45</xref>). Similarly, in China (Wuhan) the application of non-pharmaceutical interventions in the society, including a cordon sanitaire of the town; interruption of community transport, school, and most employment; and termination of all community events decreased the R<sub>o</sub> from 3.86 to 0.32 over a 5-week period (<xref rid="B46" ref-type="bibr">46</xref>). Nevertheless, these strategies could not be maintained.</p><p>Emerging research evidence (<xref rid="B29" ref-type="bibr">29</xref>) regarding sewage contamination that preceded Paris COVID-19 epidemic is pointing to the reports of 2003 from the health department of Hong Kong (<xref rid="B35" ref-type="bibr">35</xref>, <xref rid="B36" ref-type="bibr">36</xref>), the noble work by Ng (<xref rid="B13" ref-type="bibr">13</xref>), and urge for extensive environmental monitoring (<xref rid="B29" ref-type="bibr">29</xref>, <xref rid="B37" ref-type="bibr">37</xref>) to prevent future COVID-19 relapses. However, the flow of genetic variation may be even more complex as illustrated in <xref ref-type="fig" rid="F2">Figure 2</xref>. Therefore, advanced clinical and laboratory monitoring is required to prevent SSEs and thereafter, new coronavirus epidemics. Assembly of key functions and screening techniques of reference centers is presented in <xref rid="T3" ref-type="table">Table 3</xref>. Newer therapeutic agents and protocol applications are promising (<xref rid="B47" ref-type="bibr">47</xref>), although probably carrying the possibility of resistance state (<xref rid="B48" ref-type="bibr">48</xref>). First, these also require specific diagnostic and surveillance strategies to overcome any unknown adverse epidemiology consequences (<xref rid="B48" ref-type="bibr">48</xref>). Inhibiting wild meat markets and related consumption of wild meat by creating vivid campaigns could be a critical for interrupting the introduction of coronaviruses crossing from animals to the human population, as was the case for SARS (<xref rid="B1" ref-type="bibr">1</xref>, <xref rid="B4" ref-type="bibr">4</xref>, <xref rid="B5" ref-type="bibr">5</xref>) and Middle East respiratory syndrome (MERS) (<xref rid="B49" ref-type="bibr">49</xref>) epidemics, and probably now for COVID-19 pandemic (<xref rid="B1" ref-type="bibr">1</xref>-<xref rid="B3" ref-type="bibr">3</xref>). Furthermore, the food production process requires radical reconsideration, concerning the industrial environment of current food production and serious violations of natural ecosystems (<xref rid="B50" ref-type="bibr">50</xref>). Current industrial procedures for preparing food increasingly favor conditions where viral evolution produces new mutations and increased rates of mutations (<xref rid="B25" ref-type="bibr">25</xref>), thus raising the probability of new and more infectious viral strains. In SARS and MERS epidemics, the role of SSEs in vigorously distributing the epidemics has been substantially proven (<xref rid="B51" ref-type="bibr">51</xref>-<xref rid="B55" ref-type="bibr">55</xref>). The new COVID-19 epidemiology evidence also adequately highlights the important role of SSEs in homeland of China (<xref rid="B21" ref-type="bibr">21</xref>, <xref rid="B56" ref-type="bibr">56</xref>, <xref rid="B57" ref-type="bibr">57</xref>), although surprising evidence from neighboring countries show the unlikely role of SSE in the spread of the disease (<xref rid="B58" ref-type="bibr">58</xref>). </p><p>
<bold>4.5 Effective molecular screening of SARS-COV-2 and socioeconomic relations </bold>
</p><p>The <italic>Coronaviridae</italic> family is characterized by a positive-sense single-stranded RNA genome. Mouse hepatitis virus is a representative member of the family (<xref rid="B41" ref-type="bibr">41</xref>). Additionally, human hepatitis E virus also has a positive-sense single stranded RNA genome and shares a common evolution pathway with coronaviruses (<xref rid="B40" ref-type="bibr">40</xref>). Hepatitis-related incidents were described for SARS (<xref rid="B59" ref-type="bibr">59</xref>). The genetic recombination of these viruses within arbitrary intermediate hosts produced contagious strains that are extremely pathogenic to humans (<xref rid="B40" ref-type="bibr">40</xref>, <xref rid="B60" ref-type="bibr">60</xref>). In this respect, the relation of SARS-COV genetic sequences isolated from human, civets, and bats permitted us to find the reason for such a dangerous epidemic, which affected people on a worldwide scale in 2003 (<xref rid="B61" ref-type="bibr">61</xref>). Moreover, the unpredictable epidemic of MERS-COV posed a serious risk to the health of communities worldwide. These underscored the necessity for further research of the virus epidemiology and pathophysiology to develop successful therapeutic and preventive medications against MERS-COV infection (<xref rid="B62" ref-type="bibr">62</xref>). While SARS-COV-2 is genetically and structurally connected with MERS-COV, it has its own exclusive structures which are responsible for its quick spread throughout the world (<xref rid="B60" ref-type="bibr">60</xref>). </p><p>Specifically, variations in coronavirus pathogenicity within different species (<xref rid="B63" ref-type="bibr">63</xref>) make the understanding of SARS epidemics even more unclear through their capability to overcome the barrier for cross species transmission, which also alters their infectivity status (<xref rid="B14" ref-type="bibr">14</xref>, <xref rid="B64" ref-type="bibr">64</xref>). As a result, boosting the pathogenic behavior of <italic>coronavirus </italic>strains, within species (<xref rid="B65" ref-type="bibr">65</xref>), and across species barriers (<xref rid="B49" ref-type="bibr">49</xref>), which is a reflection of their positive adaptation to rapid recombination events (<xref rid="B49" ref-type="bibr">49</xref>). The recent MERS epidemic revealed the tendency of the strain to genetically adapt and produce greater outbreaks (<xref rid="B49" ref-type="bibr">49</xref>) as occurred in SARS epidemic in 2003 (<xref rid="B66" ref-type="bibr">66</xref>). However, mainly for socioeconomic reasons, alarm signals were ignored until recently (<xref rid="B67" ref-type="bibr">67</xref>). A new phylogenetic analysis technique employed on clustered COVID-19 strains displayed a geographic variation preference in infectivity and pathogenesis (<xref rid="B39" ref-type="bibr">39</xref>). This is probably due to predominating strain&#x02019;s tendency to cause an SSE as an outcome of a multi- factorial epidemic process presented in <xref ref-type="fig" rid="F2">Figure 2</xref> (<xref rid="B23" ref-type="bibr">23</xref>, <xref rid="B24" ref-type="bibr">24</xref>). Marked SSEs for COVID-19 have already been fully characterized and warrant urgent investigation (<xref rid="B23" ref-type="bibr">23</xref>, <xref rid="B24" ref-type="bibr">24</xref>). As presented in <xref rid="T3" ref-type="table">Tables 3</xref> and <xref rid="T4" ref-type="table">4</xref>, each way of transmission should be investigated. Heterogeneity of epidemic characteristics across nations (<xref rid="B39" ref-type="bibr">39</xref>) implies that in this way we may minimize coronavirus transmission. Therefore, salvation of national economic catastrophes will also be achieved in this way (<xref rid="B66" ref-type="bibr">66</xref>). Thus, the whole Biomedical Science machinery needs to perform targeted diagnosis of SSEs and share the obtained experience. Subsequently, central authorities will no longer need excessive non-specific contact measures, which will in turn normalize both societal and economic activities. </p><p>
<bold>4.6 SSE-related large outbreaks and uncontrolled austerity</bold>
</p><p>On the other hand, improper understanding of how COVID-19 spreads resulted in societal imbalance due to arbitrary restriction of social and religious life including Holy Communion Cup. It has been consecutively demonstrated by expert research that the Holy Cup (Chalice) and the Holy Cloth are not sources or pathways, for potential spreading of infectious diseases including Human Immunodeficiency virus (HIV) (<xref rid="B68" ref-type="bibr">68</xref>), Hepatitis B virus (HBV) (<xref rid="B69" ref-type="bibr">69</xref>) as well as other communicable pathogens (<xref rid="B70" ref-type="bibr">70</xref>). Specifically, a review (<xref rid="B69" ref-type="bibr">69</xref>), considered other 129 relative studies. In this review, the possibilities that the shared communion cup can act as a vehicle for indirect transmission of human immunodeficiency virus, since it was detected in the saliva of infected individuals, was investigated. It was emphasized that although for bacterial contamination, the alcoholic content of the wine, the material that the cup is made of, or the practice of partially rotating the cup, cannot stop the occasional transmission of microbes, the microbial transmission was considerably reduced by the intervening use of a cloth to swab the lip of the cup between communicants. Notably, it was emphasized that transmission means not an obligatory inoculation or infection. Furthermore, it was also emphasized that out of the epidemiology of microbes transmitted via saliva, particularly for the transmission of the herpes viruses, the indirect transmission is rare, and indeed transmission is highly possible by other means than by the saliva. It was also emphasized that neither hepatitis B virus nor human immunodeficiency virus infection can be transmitted by saliva, rendering their indirect transmission also less likely by inorganic objects. Finally, the study concluded that no episode of disease transmission has ever been reported as a result of the shared communion cup use, and that there was not any scientific evidence that the communion cup practice should be abandoned due to the possible risk of spreading of any infection (<xref rid="B71" ref-type="bibr">71</xref>, <xref rid="B72" ref-type="bibr">72</xref>). Likewise, Kingston et al. (<xref rid="B68" ref-type="bibr">68</xref>), by considering 44 relative papers, also concluded that there is no evidence that the Holy Communion Cup spreads infections. Moreover, more recent estimations also demonstrated that no infections have ever been observed as a result of religious rituals including Christian Common Communion chalice practice (<xref rid="B70" ref-type="bibr">70</xref>); whereas, data of previous studies implied that saliva could play a role in HBV transmission, are likely to be trivial (<xref rid="B69" ref-type="bibr">69</xref>). Similarly, recent evidence indicate that, although HBV&#x000a0;DNA and HCV RNA can be discovered in the&#x000a0;saliva&#x000a0;of infected patients, they seem unlikely to transmit infection (<xref rid="B72" ref-type="bibr">72</xref>). It should be noted that, as in the case of coronavirus (<xref rid="B73" ref-type="bibr">73</xref>, <xref rid="B74" ref-type="bibr">74</xref>), HBV also exists in many body fluids including saliva, nasopharyngeal fluid or tears by measures of qualitative and PCR methods (<xref rid="B75" ref-type="bibr">75</xref>). </p><p>The detection of HBV DNA in saliva motivated our study group to investigate the potential viral transmission through the Holy Communion Cup. Two successive retrospective studies were conducted to investigate the role of Holy Communion as an independent risk factor of HBV dispersion. The first preliminary study included patients from our registry of those with chronic hepatitis B under entecavir (Jannis Kountouras-personal communication) treatment (<xref rid="B76" ref-type="bibr">76</xref>), and in the next step, the relative registry of another Department of the same Hospital was incorporated. Other parameters studied, the substantial independent categorical variable to evaluate our hypothesis was the patients&#x02019; occupation, thereby introducing two sub-groups; priests and non-priests. This classification was performed based on a standard active and perpetual exhibition (at least once weekly) of priests to many people&#x02019;s saliva, as a part of the grounded process of the Holy Communion Cup. The control group comprised of the aggregate of Orthodox priests in Greece (10,338) and the rest general population (10,680,866) at that timeframe. Approval of the Institutional Ethics Committee was obtained and all predispositions of the Helsinki Declaration were fulfilled. The reservoir database did not include any personified information (name, ID number, etc.) and thus no informed consent was required. Pearson's chi-squared test with 1 degree of freedom was performed to evaluate whether there was a statistically significant difference between the frequencies of HBV infection in case and control groups and statistical significance was set at <italic>p &#x0003c;</italic><italic>0.05</italic>.</p><p>The first single-centre registry included 71 patients and one (1.4%) of them was a priest. Chronic hepatitis B was significantly more frequent among non-priests compared to priests (x<sup>2</sup> (1, N=71)=12.65, <italic>p &#x0003c;0.05</italic>). The extended sample (N=429) included the registry of another Department and an aggregate of four (0.93%) priests were diagnosed with chronic hepatitis B. Likewise, the chi-square test revealed that non-priest subjects were more likely to suffer from chronic hepatitis from HBV infection compared to priests (x<sup>2</sup> (1, N=429) = 31, <italic>p &#x0003c;0.001</italic>). In conclusion, both of our analyses indicated a lower prevalence of HBV chronic hepatitis among priests when compared to other occupations. </p><table-wrap id="T1" position="float"><label>Table 1</label><caption><p>Literature included from PubMed search for SSEs<sup>*</sup> in relation to coronavirus outbreaks</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="center" valign="middle" colspan="4" rowspan="1">
<bold>Literature included in review for SARS</bold>
<sup>^</sup>
<bold> and MERS</bold>
<sup>!</sup>
<bold> in relation to SSEs</bold>
<sup>*</sup>
<hr/>
</th></tr><tr><th align="left" valign="middle" colspan="2" rowspan="1">Authors and Year</th><th align="left" valign="middle" rowspan="1" colspan="1">Type of article<sup>**</sup></th><th align="left" valign="middle" rowspan="1" colspan="1">Study description </th></tr></thead><tbody><tr><td align="left" valign="middle" colspan="2" rowspan="1">Chowell et al. (2015)(<xref rid="B51" ref-type="bibr">51</xref>) </td><td align="left" valign="middle" rowspan="1" colspan="1">Comparative research</td><td align="left" valign="middle" rowspan="1" colspan="1">Investigation of relation between SSEs for SARS and MERS transmission in nosocomial outbreaks </td></tr><tr><td align="left" valign="middle" colspan="2" rowspan="1">Al Tawfig et al. (2020) (<xref rid="B38" ref-type="bibr">38</xref>)</td><td align="left" valign="middle" rowspan="1" colspan="1">Commentary</td><td align="left" valign="middle" rowspan="1" colspan="1">Demonstration of a stochastic model of transmission of SARS virus</td></tr><tr><td align="left" valign="middle" colspan="2" rowspan="1">Shaw (2006) (<xref rid="B55" ref-type="bibr">55</xref>)</td><td align="left" valign="middle" rowspan="1" colspan="1">Perspective review</td><td align="left" valign="middle" rowspan="1" colspan="1">Implementing efficient intensive care practices to avoid hospital transmission </td></tr><tr><td align="left" valign="middle" colspan="2" rowspan="1">Chen et al. (2006) (<xref rid="B96" ref-type="bibr">96</xref>)</td><td align="left" valign="middle" rowspan="1" colspan="1">Original research<break/>Case control study</td><td align="left" valign="middle" rowspan="1" colspan="1">Investigation of SSE likelihood during hospital transmission</td></tr><tr><td align="left" valign="middle" colspan="2" rowspan="1">Sung et al. (2009) (<xref rid="B97" ref-type="bibr">97</xref>)</td><td align="left" valign="middle" rowspan="1" colspan="1">Original research<break/>Case control study</td><td align="left" valign="middle" rowspan="1" colspan="1">Investigation of SSEs occurring in hospital and prevention strategies</td></tr><tr><td align="left" valign="middle" colspan="2" rowspan="1">Li et al. (2004) (<xref rid="B54" ref-type="bibr">54</xref>)</td><td align="left" valign="middle" rowspan="1" colspan="1">Original research<break/>Case control study</td><td align="left" valign="middle" rowspan="1" colspan="1">Investigation of factors contributing to SSEs for prevention and control of disease</td></tr><tr><td align="left" valign="middle" colspan="2" rowspan="1">Riley (2003) (<xref rid="B5" ref-type="bibr">5</xref>)</td><td align="left" valign="middle" rowspan="1" colspan="1">Original research<break/>Cross sectional study</td><td align="left" valign="middle" rowspan="1" colspan="1">Analysis of SARS epidemiology in Hong Kong</td></tr><tr><td align="left" valign="middle" colspan="2" rowspan="1">Stein (2011) (<xref rid="B98" ref-type="bibr">98</xref>)</td><td align="left" valign="middle" rowspan="1" colspan="1">Perspective review</td><td align="left" valign="middle" rowspan="1" colspan="1">Analysis of SARS transmission leading to SSE</td></tr><tr><td align="left" valign="middle" colspan="2" rowspan="1">Gormely et al. (2017) (<xref rid="B52" ref-type="bibr">52</xref>)</td><td align="left" valign="middle" rowspan="1" colspan="1">Original research</td><td align="left" valign="middle" rowspan="1" colspan="1">Model for prevention of pathogen transmission via sanitary plumping systems</td></tr><tr><td align="left" valign="middle" colspan="2" rowspan="1">Lau (2004) (<xref rid="B53" ref-type="bibr">53</xref>)</td><td align="left" valign="middle" rowspan="1" colspan="1">Perspective review</td><td align="left" valign="middle" rowspan="1" colspan="1">Implementation of SSE containment with vaccination programs</td></tr><tr><td align="left" valign="middle" colspan="4" rowspan="1">
<bold>Literature included in review for COVID-19 in relation to SSEs</bold>
</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Cave (2020) (<xref rid="B56" ref-type="bibr">56</xref>)</td><td align="left" valign="middle" colspan="2" rowspan="1">Perspective review</td><td align="left" valign="middle" rowspan="1" colspan="1">Call for clear epidemiologic definition for SSEs</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Xu (2020) (<xref rid="B57" ref-type="bibr">57</xref>)</td><td align="left" valign="middle" colspan="2" rowspan="1">Original research<break/>Retrospective cohort study</td><td align="left" valign="middle" rowspan="1" colspan="1">Analysis of SSEs during COVID-19 in China</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Kwok (2020) (<xref rid="B58" ref-type="bibr">58</xref>)</td><td align="left" valign="middle" colspan="2" rowspan="1">Original research</td><td align="left" valign="middle" rowspan="1" colspan="1">Analysis of SSE influence in the nature of COVID-19 epidemic</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Zhang (2020)(<xref rid="B21" ref-type="bibr">21</xref>) </td><td align="left" valign="middle" colspan="2" rowspan="1">Original research</td><td align="left" valign="middle" rowspan="1" colspan="1">Description of SSE importance in COVID-19 epidemic </td></tr></tbody></table><table-wrap-foot><p>
<sup>! </sup>Severe Acute Respiratory Syndrome; <sup>^ </sup>Middle East Respiratory Syndrome; <sup>&#x00026;</sup>Coronavirus Disease-19;<sup> *</sup>Super Spread Events;<sup> **</sup>When clearly indicated in article, the type of study is also mentioned. </p></table-wrap-foot></table-wrap><table-wrap id="T2" position="float"><label>Table 2</label><caption><p>The search results of literature related to COVID-19&#x00026; global impact due to SSEs<sup>*</sup></p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" valign="middle" rowspan="1" colspan="1">
<bold>Search Item </bold>
</th><th align="left" valign="middle" rowspan="1" colspan="1">
<bold>Medline</bold>
<break/>
<bold>/PubMed</bold>
</th><th align="left" valign="middle" rowspan="1" colspan="1">
<bold>Other electronic sources**</bold>
</th><th align="left" valign="middle" rowspan="1" colspan="1">
<bold>Number of articles retrieved </bold>
</th><th align="left" valign="middle" rowspan="1" colspan="1">
<bold>Number of articles included </bold>
</th></tr></thead><tbody><tr><td align="left" valign="middle" rowspan="1" colspan="1">SARS<sup>!</sup>, MERS<sup>^</sup>, and COVID-19 epidemic prevention </td><td align="left" valign="middle" rowspan="1" colspan="1">42</td><td align="left" valign="middle" rowspan="1" colspan="1">3589</td><td align="left" valign="middle" rowspan="1" colspan="1">139</td><td align="left" valign="middle" rowspan="1" colspan="1">17</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">SARS, MERS, and COVID-19 infectivity and pathogenicity</td><td align="left" valign="middle" rowspan="1" colspan="1">672</td><td align="left" valign="middle" rowspan="1" colspan="1">3812</td><td align="left" valign="middle" rowspan="1" colspan="1">145</td><td align="left" valign="middle" rowspan="1" colspan="1">18</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Coronavirus SSE prevention</td><td align="left" valign="middle" rowspan="1" colspan="1">10</td><td align="left" valign="middle" rowspan="1" colspan="1">627</td><td align="left" valign="middle" rowspan="1" colspan="1">151</td><td align="left" valign="middle" rowspan="1" colspan="1">22</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">SSE, coronavirus crisis, and socio-economics</td><td align="left" valign="middle" rowspan="1" colspan="1">4</td><td align="left" valign="middle" rowspan="1" colspan="1">3181</td><td align="left" valign="middle" rowspan="1" colspan="1">89</td><td align="left" valign="middle" rowspan="1" colspan="1">11</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Holy Cup religion and transmission of pathogens and SSEs</td><td align="left" valign="middle" rowspan="1" colspan="1">0</td><td align="left" valign="middle" rowspan="1" colspan="1">15</td><td align="left" valign="middle" rowspan="1" colspan="1">4</td><td align="left" valign="middle" rowspan="1" colspan="1">4</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Coronavirus immunity and vaccination</td><td align="left" valign="middle" rowspan="1" colspan="1">73</td><td align="left" valign="middle" rowspan="1" colspan="1">20975</td><td align="left" valign="middle" rowspan="1" colspan="1">1175</td><td align="left" valign="middle" rowspan="1" colspan="1">9</td></tr></tbody></table><table-wrap-foot><p>
<sup>&#x00026;</sup>Coronavirus Disease-19; <sup>*</sup>Super Spread Events; ** Science Direct, SciFinder, and Google Scholar; <sup>!</sup>Severe Acute Respiratory Syndrome; <sup>^</sup>Middle East Respiratory Syndrome</p></table-wrap-foot></table-wrap><table-wrap id="T3" position="float"><label>Table 3</label><caption><p>Key clinical and laboratory screening functions to appropriately forecast, prevent, and confront SARS<sup>!</sup> Coronavirus 2, and future coronavirus epidemic waves</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" rowspan="1" colspan="1">
<bold>Specific Clinical and Laboratory Investigation</bold>
</th><th align="left" rowspan="1" colspan="1">
<bold>Validated techniques to be used</bold>
</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">
<bold>Forecasting of pre-symptomatic infection </bold>
</td><td align="left" rowspan="1" colspan="1">To estimate the probability of a major outbreak, use simulations of stochastic compartmental epidemic models. Use of diagnostic tests to detect asymptomatic susceptibility and pre-symptomatic infectivity </td></tr><tr><td align="left" rowspan="1" colspan="1">
<bold>Estimation of Super Spread Events of current and previous coronavirus epidemics </bold>
</td><td align="left" rowspan="1" colspan="1">Introduction of individual reproductive number. Integrated and computational analysis of the influence of individual variation by binomial distribution and use of branching process analysis of disease data<bold>.</bold></td></tr><tr><td align="left" rowspan="1" colspan="1">
<bold>Genetic characterization of inpatient viral isolates to identify intermediate animal hosts facilitating the infection</bold>
</td><td align="left" rowspan="1" colspan="1">Next generation sequencing of samples and cultured viral isolates to obtain full sequence and phylogenetic analysis application. </td></tr><tr><td align="left" rowspan="1" colspan="1">
<bold>Environmental detection and continuous sewage monitoring</bold>
</td><td align="left" rowspan="1" colspan="1">RT-qPCR<sup>#</sup> screening on sewage systems, vectors&#x00648; and potential air transmission. Autopsies and detection of serology conversion of potential vectors. </td></tr><tr><td align="left" rowspan="1" colspan="1">
<bold>Heptad repeat region screening for positive selection </bold>
</td><td align="left" rowspan="1" colspan="1">Computer simulation models to detect positive selection events e.g. <italic>codeml branch-site </italic>Test coupled with Bayes empirical Bayes procedure, and mixed effects model of evolution. </td></tr><tr><td align="left" rowspan="1" colspan="1">
<bold>Receptor recognition analysis of ACE-II</bold>
<sup>+</sup>
<bold> to identify origin of cross-species and human to human transmissions coronaviruses</bold>
</td><td align="left" rowspan="1" colspan="1">Genetic sequencing and phylogenetic analysis of ACE-II to provide origin and efficiency of cross-species and human to human transmission and identification of intermediate hosts. </td></tr></tbody></table><table-wrap-foot><p>
<sup>!</sup>Severe Acute Respiratory Syndrome; <sup>#</sup>Reverse Transcriptase Quantitative Polymerase Chain reaction; <sup>+</sup>Angiotensin-converting enzyme-II. </p></table-wrap-foot></table-wrap><table-wrap id="T4" position="float"><label>Table 4</label><caption><p>Potential groups of coronavirus super spreaders within the human population<sup>*</sup></p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" valign="middle" rowspan="1" colspan="1">
<bold>Population Group</bold>
</th><th align="left" valign="middle" rowspan="1" colspan="1">
<bold>Potential route of transmission</bold>
</th></tr></thead><tbody><tr><td align="left" valign="middle" rowspan="1" colspan="1">Hepatitis B and C virus positive patients </td><td align="left" valign="middle" rowspan="1" colspan="1">Airborne </td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Pulmonary tuberculosis positive patients </td><td align="left" valign="middle" rowspan="1" colspan="1">Airborne </td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">HIV<sup>!</sup> positive patients </td><td align="left" valign="middle" rowspan="1" colspan="1">Airborne, urine &#x00026; fecal-oral (98)</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Patients receiving hemodialysis </td><td align="left" valign="middle" rowspan="1" colspan="1">Airborne (droplets by nebulizer) and fecal-oral </td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">MRSA<sup>#</sup><italic> Staphylococcus aureus</italic> acquisition</td><td align="left" valign="middle" rowspan="1" colspan="1">Constant Worn Glove Contact Transmission </td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Rhinovirus co-infections</td><td align="left" valign="middle" rowspan="1" colspan="1">Airborne </td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Gastrointestinal <italic>(Salmonella enteritis)</italic>
<break/>co-infections</td><td align="left" valign="middle" rowspan="1" colspan="1">Fecal &#x02013; oral </td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Frequent contact with wild animal reservoirs (including domestic animals) and birds<sup>**</sup></td><td align="left" valign="middle" rowspan="1" colspan="1">Airborne and fecal &#x02013; oral </td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Construction area workers </td><td align="left" valign="middle" rowspan="1" colspan="1">Air particles </td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Sewage system workers<sup>***</sup>
</td><td align="left" valign="middle" rowspan="1" colspan="1">Fecal &#x02013; oral </td></tr></tbody></table><table-wrap-foot><p>
<sup>*</sup>In both community and hospital environments. </p><p>
<sup>**</sup>Including slaughter houses, pet shops, animal and bird collectors and breeders, cow, and pig farmers. </p><p>
<sup>***</sup>Including workers coming in contact with environment contamination. </p><p>
<sup>!</sup>Human Immunodeficiency Virus, <sup>#</sup>Methicillin Resistant <italic>Staphylococcus aureus</italic>.</p></table-wrap-foot></table-wrap><fig id="F1" position="float"><label>Figure 1</label><caption><p>Method followed for PubMed search and literature selection regarding SSE in relation to a) SARS-1, MERS and b) COVID-19 outbreaks</p></caption><graphic xlink:href="aaem-8-e74-g001"/></fig><fig id="F2" position="float"><label>Figure 2</label><caption><p>Flow of genetic variation of coronaviruses leading to increase of virulence and pathogenicity; epidemiologic steps for specific and targeted diagnosis to prevent super spread events. Blue arrows point to the flow of genetic variation across gene pools where genetic variation occurs, i.e. a) between hosts of the same species, b) between hosts of different species by crossing the species barrier, spreading to c) humans and subsequently to super spreader individuals, where disease transmission is potentiated. Grey arrows point to specific identifications that can lead to effective interventions with the potential to control the disease spread</p></caption><graphic xlink:href="aaem-8-e74-g002"/></fig><p>
<bold>4.7 Coronavirus vaccination and relationship with SSEs </bold>
</p><p>Currently, vaccines for COVID-19 are in pre-clinical development, and no final clinical phase has been ended due the recent emergence of the disorder. Many global entities have stated their plans to produce a vaccine for COVID-19. According to the WHO, 41 candidate vaccines are being produced for COVID-19 as of March 13, 2020 (<xref rid="B77" ref-type="bibr">77</xref>). Importantly, for production of highly effective and safe COVID-19 vaccines, features such as the possibility of the induction of antigen-dependent enhancement (ADE) and additional severe opposing effects previously detected with SARS and MERS should be considered. ADE is a phenomenon that occurs when non-neutralizing antibodies against proteins of a virus increase, also increasing virus infectivity (<xref rid="B78" ref-type="bibr">78</xref>). In this regard, coronaviruses can escape the immunity provided by inactivated or recombinant protein vaccines via fast evolution (<xref rid="B79" ref-type="bibr">79</xref>). The problem with live attenuated vaccines is that the coronavirus can recover its virulence via serial passages in cell culture or <italic>in vivo</italic> (<xref rid="B80" ref-type="bibr">80</xref>). Moreover, vaccination in animals and humans could facilitate, rather than inhibit, the pathogenesis of the targeted viruses. This can be the consequence of an ADE phenomenon. This underlines a mechanism by which specific antibodies facilitate infection with the targeted virus, or cell-based augmentation, a process resulting in an allergic inflammatory response induced by immunopathology (<xref rid="B81" ref-type="bibr">81</xref>, <xref rid="B82" ref-type="bibr">82</xref>).</p><p>
<bold>Many experimental SARS-CoV-1 vaccines have been formulated from whole inactivated viruses, due to their advantage of large-scale production, multiple epitope presentation and high conformation stability (</bold>
<xref rid="B83" ref-type="bibr">83</xref>
<bold>). One such vaccine uses viruses from AY71A217 strain of SARS-CoV-1, which are double inactivated using formalin and UV irradiation, the so-called double-inactivated virus (DIV) vaccine (</bold>
<xref rid="B84" ref-type="bibr">84</xref>
<bold>). Although DIV had initially been demonstrated to induce neutralizing antibodies and to protect against SARS-CoV-1 viral replication, both in tissue culture and in young mice, it soon became apparent that older mice suffered from vaccine-induced immune pathologies, including failure to contain viral replication, augmented clinical disease and associated symptoms, and increased inflammatory response and eosinophilic influx (</bold>
<xref rid="B84" ref-type="bibr">84</xref>
<bold>, </bold>
<xref rid="B85" ref-type="bibr">85</xref>
<bold>). In this respect, there is </bold>
<bold>an overlap between the immunopathologic responses connected with coronavirus disease and vaccination, and the role of T helper (Th) 17 cells in immune augmentation and eosinophilic lung immunopathology; host Th17 polarized inflammatory reactions portray an important role in the pathophysiology of COVID-19 pneumonia and edema</bold>&#x000a0;<bold>(</bold><xref rid="B86" ref-type="bibr">86</xref><bold>, </bold><xref rid="B87" ref-type="bibr">87</xref><bold>).</bold><bold> Eosinophilic pathology, indicating increased pathogenesis and disease severity in the elderly, has been attributed to the nucleocapsid (N) protein, despite the incorporation of multiple SARS-CoV-1 antigens in the DIV (</bold><xref rid="B82" ref-type="bibr">82</xref><bold>, </bold><xref rid="B84" ref-type="bibr">84</xref><bold>). This is on grounds that the N protein is a strong modulator of innate immunity, also acting as an interferon antagonist, and therefore, it has the capability to induce inflammation with subsequent immune pathology in situations of heterologous viral challenge or in immune senescence, where patients fail to mount effective immune responses against the disease (</bold><xref rid="B84" ref-type="bibr">84</xref><bold>, </bold><xref rid="B88" ref-type="bibr">88</xref><bold>). The route of transmission is important to be established for SARS COV-2. As seen with other important infectious diseases of a) air borne transmission such as tuberculosis (</bold><xref rid="B89" ref-type="bibr">89</xref><bold>), b) orofecal transmission such as HEV (</bold><xref rid="B90" ref-type="bibr">90</xref><bold>) and c) blood transmission such as HBV and hepatitis D virus (</bold><xref rid="B91" ref-type="bibr">91</xref><bold>), even if efficient vaccination is established, understanding of SSEs is still important. Recent research data on the immune receptors used by coronaviruses, which reflect their ability to propagate in the human population, imply that complex immune reactions are responsible for a cell to cell transmission. In addition to ACE-II receptor, as is the case with SARS-COV, MERS-COV (</bold><xref rid="B92" ref-type="bibr">92</xref><bold>) and possibly for SARS-COV-2 (</bold><xref rid="B92" ref-type="bibr">92</xref><bold>, </bold><xref rid="B93" ref-type="bibr">93</xref><bold>), viruses use complex receptor recognition systems common to immunopathology damage mechanisms in coronavirus-infected individuals, which clearly define the clinical outcome (</bold><xref rid="B94" ref-type="bibr">94</xref><bold>). Therefore, application of vaccines that may interfere with antibody-mediated infection by coronaviruses (</bold><xref rid="B95" ref-type="bibr">95</xref><bold>) without true epidemiologic containment of coronaviruses, to restrict genetic adaptation events and inevitably producing an SSE, may be a miscellaneous attempt. However, synergy of SSE prevention measures with proper vaccination can provide a robust attempt for disease containment. </bold></p></sec><sec><title>Limitations</title><p>This study aimed to perform a literature review. Although effort was made to decrease the risk of bias of results via double-blind screening of literature and employment of multiple electronic search engines, bias cannot be eliminated due to incomplete retrieval of identified research and biased estimations of included literature conclusions and methods used. Outcome of the study may also contain biased estimations originating from wrong interpretation of super spreading individuals in literature reviewed for SARS, MERS, and COVID-19 outbreaks. Although the importance of SSEs in COVID-19 was recognized by this study, more data from future accumulated epidemiology studies are needed to justify these findings. </p></sec><sec sec-type="conclusions"><title>Conclusions</title><p>Taken all together, management of SSEs is mandatory to yield efficient control over SARS-CoV-2. This is achievable through early diagnosis of pre/asymptomatic infected individuals within potential super spreading groups. Prevention of outbreaks is more essential, especially due to the lack of efficient vaccination and therapeutic protocols, which necessitates efficient monitoring, as SARS-COV-2 virus follows complex infectious patterns. The SARS-COV-2 epidemiological models that do not take SSEs into consideration seem to lead to confusing results with high uncertainty. SARS-CoV-2 causes prolonged &#x0201c;pandemics&#x0201d; through complex adaptation routes. Currently, in addition to the high technology utilized for diagnosis, clinical observation is indispensable to deeply comprehend SSEs and prohibit further outspread of COVID-19. Reference laboratories with efficient and accredited molecular and serological diagnosis must be inter-linked between countries. All these parameters could contribute to avoiding a second blind unjustified response that characterized the first COVID-19 pandemic spread. Understanding the epidemiology of COVID-19 through SSEs could be preventive for future epidemics. A systematic meta-analysis research methodology, when COVID-19 epidemiology data accumulate further, would be advisable to confirm the conclusions of this study.</p></sec><sec><title>Ethics approval and consent to participate</title><p>This study did not involve the participation of any humans or animals as it was based only on literature research. </p></sec><sec><title>Consent for publication</title><p>All authors agree to publish this manuscript. </p></sec><sec sec-type="data-availability"><title>Availability of data and materials</title><p>All data used for this manuscript are available upon request </p></sec><sec><title>Competing interests</title><p>All authors declare that they have no competing interests. </p></sec><sec><title>Funding</title><p>No funding or grant was received for this study. </p></sec></body><back><ack><title>Acknowledgements</title><p>We thank our families for providing moral assistance to accomplish this study. </p></ack><sec><title>Author contribution</title><p>AK inspired the conception and drafted the initial manuscript. JK revised substantially the manuscript, intellectual content and provided disclosed data for HBV investigation. AK and JK made the primary double-blind search. AP, JK, AK, MN, and NG, made all other searches. AP contributed to the immunology aspect of manuscript. AP and NG aided in the clinical part and preparing the final version of the manuscript. MD contributed to bibliographical search and revision of the manuscript. All authors contributed to the English editing of the manuscript. </p></sec><sec><title>Abbreviations</title><p>SARS: Severe acute respiratory syndrome.</p><p>SARS-COV-2: Severe acute respiratory syndrome coronavirus -2. </p><p>SSEs: Super spread events.</p><p>COVID-19: Coronavirus disease 2019.</p><p>SADS: Swine acute diarrhea syndrome.</p><p>R<sub>o</sub>: Basic reproduction number.</p><p>IQR: Interquartile range.</p><p>MERS-COV: Middle East Respiratory Syndrome coronavirus. </p><p>HIV: Human Immunodeficiency virus</p><p>HBV: (Human) Hepatitis B virus</p><p>HCV: (Human) Hepatitis C virus</p><p>ADE: Antigen dependent enhancement</p><p>DIV: Double Inactivated virus</p><p>Th: T helper (cell)</p><p>RT-qPCR: Reverse transcriptase quantitative polymerase chain reaction</p><p>ACE-II: Angiotensin converting enzyme II</p><p>MRSA: Methicillin resistant <italic>Staphylococcus aureus</italic>
</p></sec><ref-list><title>References</title><ref id="B1"><label>1</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dong</surname><given-names>N</given-names></name><name><surname>Yang</surname><given-names>X</given-names></name><name><surname>Ye</surname><given-names>L</given-names></name><name><surname>Chen</surname><given-names>K</given-names></name><name><surname>Chan</surname><given-names>EW-C</given-names></name><name><surname>Yang</surname><given-names>M</given-names></name><etal/></person-group><article-title>Genomic and protein structure modelling analysis depicts the origin and infectivity of 2019-nCoV, a new coronavirus which caused a pneumonia outbreak in Wuhan, China</article-title><source> bioRxiv</source><year>2020</year><volume>32</volume><issue>1</issue><fpage>2020.01.20.913368</fpage><lpage>2020</lpage></element-citation></ref><ref id="B2"><label>2</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Petrosillo</surname><given-names>N</given-names></name><name><surname>Viceconte</surname><given-names>G</given-names></name><name><surname>Ergonul</surname><given-names>O</given-names></name><name><surname>Ippolito</surname><given-names>G</given-names></name><name><surname>Petersen</surname><given-names>E</given-names></name></person-group><article-title>COVID-19, SARS and MERS: are they closely related?</article-title><source> Clinical Microbiology and Infection</source><year>2020</year></element-citation></ref><ref id="B3"><label>3</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wan</surname><given-names>Y</given-names></name><name><surname>Shang</surname><given-names>J</given-names></name><name><surname>Graham</surname><given-names>R</given-names></name><name><surname>Baric</surname><given-names>RS</given-names></name><name><surname>Li</surname><given-names>F</given-names></name></person-group><article-title>Receptor Recognition by the Novel Coronavirus from Wuhan: an Analysis Based on Decade-Long Structural Studies of SARS Coronavirus</article-title><source> Journal of Virology</source><year>2020</year><volume>94</volume><fpage>7</fpage></element-citation></ref><ref id="B4"><label>4</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lloyd-Smith</surname><given-names>JO</given-names></name><name><surname>Schreiber</surname><given-names>SJ</given-names></name><name><surname>Kopp</surname><given-names>PE</given-names></name><name><surname>Getz</surname><given-names>WM</given-names></name></person-group><article-title>Superspreading and the effect of individual variation on disease emergence</article-title><source> Nature</source><year>2005</year><volume>438</volume><issue>7066</issue><fpage>355</fpage><lpage>9</lpage><pub-id pub-id-type="pmid">16292310</pub-id></element-citation></ref><ref id="B5"><label>5</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Riley</surname><given-names>S</given-names></name></person-group><article-title>Transmission Dynamics of the Etiological Agent of SARS in Hong Kong: Impact of Public Health Interventions</article-title><source> Science</source><year>2003</year><volume>300</volume><issue>5627</issue><fpage>1961</fpage><lpage>6</lpage><pub-id pub-id-type="pmid">12766206</pub-id></element-citation></ref><ref id="B6"><label>6</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kucharski</surname><given-names>AJ</given-names></name><name><surname>Althaus</surname><given-names>CL</given-names></name></person-group><article-title>The role of superspreading in Middle East respiratory syndrome coronavirus (MERS-CoV) transmission</article-title><source> Eurosurveillance</source><year>2015</year><volume>20</volume><fpage>25</fpage><pub-id pub-id-type="pmid">25860393</pub-id></element-citation></ref><ref id="B7"><label>7</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wong</surname><given-names>G</given-names></name><name><surname>Liu</surname><given-names>W</given-names></name><name><surname>Liu</surname><given-names>Y</given-names></name><name><surname>Zhou</surname><given-names>B</given-names></name><name><surname>Bi</surname><given-names>Y</given-names></name><name><surname>Gao</surname><given-names>GF</given-names></name></person-group><article-title>MERS, SARS, and Ebola: The Role of Super-Spreaders in Infectious Disease</article-title><source> Cell Host &#x00026; Microbe</source><year>2015</year><volume>18</volume><issue>4</issue><fpage>398</fpage><lpage>401</lpage><pub-id pub-id-type="pmid">26468744</pub-id></element-citation></ref><ref id="B8"><label>8</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Adegboye</surname><given-names>OA</given-names></name><name><surname>Elfaki</surname><given-names>F</given-names></name></person-group><article-title>Network Analysis of MERS Coronavirus within Households, Communities, and Hospitals to Identify Most Centralized and Super-Spreading in the Arabian Peninsula, 2012 to 2016</article-title><source> Canadian Journal of Infectious Diseases and Medical Microbiology</source><year>2018</year><volume>2018</volume><fpage>1</fpage><lpage>9</lpage></element-citation></ref><ref id="B9"><label>9</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Frieden</surname><given-names>TR</given-names></name><name><surname>Lee</surname><given-names>CT</given-names></name></person-group><article-title>Identifying and Interrupting Superspreading Events&#x02014;Implications for Control of Severe Acute Respiratory Syndrome Coronavirus 2</article-title><source> Emerging Infectious Diseases</source><year>2020</year><volume>26</volume><fpage>6</fpage></element-citation></ref><ref id="B10"><label>10</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brooks</surname><given-names>SK</given-names></name><name><surname>Webster</surname><given-names>RK</given-names></name><name><surname>Smith</surname><given-names>LE</given-names></name><name><surname>Woodland</surname><given-names>L</given-names></name><name><surname>Wessely</surname><given-names>S</given-names></name><name><surname>Greenberg</surname><given-names>N</given-names></name><etal/></person-group><article-title>The psychological impact of quarantine and how to reduce it: rapid review of the evidence</article-title><source> The Lancet</source><year>2020</year><volume>395</volume><issue>10227</issue><fpage>912</fpage><lpage>20</lpage></element-citation></ref><ref id="B11"><label>11</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Holt-Lunstad</surname><given-names>J</given-names></name><name><surname>Smith</surname><given-names>TB</given-names></name><name><surname>Baker</surname><given-names>M</given-names></name><name><surname>Harris</surname><given-names>T</given-names></name><name><surname>Stephenson</surname><given-names>D</given-names></name></person-group><article-title>Loneliness and Social Isolation as Risk Factors for Mortality</article-title><source> Perspectives on Psychological Science</source><year>2015</year><volume>10</volume><issue>2</issue><fpage>227</fpage><lpage>37</lpage><pub-id pub-id-type="pmid">25910392</pub-id></element-citation></ref><ref id="B12"><label>12</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pae</surname><given-names>C-U</given-names></name></person-group><article-title>Why Systematic Review rather than Narrative Review?</article-title><source> Psychiatry Investigation</source><year>2015</year><volume>12</volume><issue>3</issue><fpage>417</fpage><pub-id pub-id-type="pmid">26207140</pub-id></element-citation></ref><ref id="B13"><label>13</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ng</surname><given-names>SKC</given-names></name></person-group><article-title>Possible role of an animal vector in the SARS outbreak at Amoy Gardens</article-title><source> The Lancet</source><year>2003</year><volume>362</volume><issue>9383</issue><fpage>570</fpage><lpage>2</lpage></element-citation></ref><ref id="B14"><label>14</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Perlman</surname><given-names>S</given-names></name><name><surname>Netland</surname><given-names>J</given-names></name></person-group><article-title>Coronaviruses post-SARS: update on replication and pathogenesis</article-title><source> Nature Reviews Microbiology</source><year>2009</year><volume>7</volume><issue>6</issue><fpage>439</fpage><lpage>50</lpage><pub-id pub-id-type="pmid">19430490</pub-id></element-citation></ref><ref id="B15"><label>15</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shen</surname><given-names>Z</given-names></name><name><surname>Ning</surname><given-names>F</given-names></name><name><surname>Zhou</surname><given-names>W</given-names></name><name><surname>He</surname><given-names>X</given-names></name><name><surname>Lin</surname><given-names>C</given-names></name><name><surname>Chin</surname><given-names>DP</given-names></name><etal/></person-group><article-title>Superspreading SARS Events, Beijing, 2003</article-title><source> Emerging Infectious Diseases</source><year>2004</year><volume>10</volume><issue>2</issue><fpage>256</fpage><lpage>60</lpage><pub-id pub-id-type="pmid">15030693</pub-id></element-citation></ref><ref id="B16"><label>16</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Taguchi</surname><given-names>F</given-names></name><name><surname>Matsuyama</surname><given-names>S</given-names></name></person-group><article-title>Soluble Receptor Potentiates Receptor-Independent Infection by Murine Coronavirus</article-title><source> Journal of Virology</source><year>2002</year><volume>76</volume><issue>3</issue><fpage>950</fpage><lpage>8</lpage><pub-id pub-id-type="pmid">11773370</pub-id></element-citation></ref><ref id="B17"><label>17</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Woolhouse</surname><given-names>MEJ</given-names></name><name><surname>Dye</surname><given-names>C</given-names></name><name><surname>Etard</surname><given-names>JF</given-names></name><name><surname>Smith</surname><given-names>T</given-names></name><name><surname>Charlwood</surname><given-names>JD</given-names></name><name><surname>Garnett</surname><given-names>GP</given-names></name><etal/></person-group><article-title>Heterogeneities in the transmission of infectious agents: Implications for the design of control programs</article-title><source> Proceedings of the National Academy of Sciences</source><year>1997</year><volume>94</volume><issue>1</issue><fpage>338</fpage><lpage>42</lpage></element-citation></ref><ref id="B18"><label>18</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Frulloni</surname><given-names>L</given-names></name><name><surname>Lunardi</surname><given-names>C</given-names></name><name><surname>Simone</surname><given-names>R</given-names></name><name><surname>Dolcino</surname><given-names>M</given-names></name><name><surname>Scattolini</surname><given-names>C</given-names></name><name><surname>Falconi</surname><given-names>M</given-names></name><etal/></person-group><article-title>Identification of a Novel Antibody Associated with Autoimmune Pancreatitis</article-title><source> New England Journal of Medicine</source><year>2009</year><volume>361</volume><issue>22</issue><fpage>2135</fpage><lpage>42</lpage><pub-id pub-id-type="pmid">19940298</pub-id></element-citation></ref><ref id="B19"><label>19</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Guarneri</surname><given-names>F</given-names></name><name><surname>Guarneri</surname><given-names>C</given-names></name><name><surname>Benvenga</surname><given-names>S</given-names></name></person-group><article-title>Helicobacter pylori and autoimmune pancreatitis: role of carbonic anhydrase via molecular mimicry?</article-title><source> Journal of Cellular and Molecular Medicine</source><year>2005</year><volume>9</volume><issue>3</issue><fpage>741</fpage><lpage>4</lpage><pub-id pub-id-type="pmid">16202223</pub-id></element-citation></ref><ref id="B20"><label>20</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kountouras</surname><given-names>J</given-names></name><name><surname>Zavos</surname><given-names>C</given-names></name><name><surname>Gavalas</surname><given-names>E</given-names></name><name><surname>Tzilves</surname><given-names>D</given-names></name></person-group><article-title>Challenge in the Pathogenesis of Autoimmune Pancreatitis: Potential Role of Helicobacter pylori Infection via Molecular Mimicry</article-title><source> Gastroenterology</source><year>2007</year><volume>133</volume><issue>1</issue><fpage>368</fpage><lpage>9</lpage><pub-id pub-id-type="pmid">17631165</pub-id></element-citation></ref><ref id="B21"><label>21</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>D-h</given-names></name><name><surname>Wu</surname><given-names>K-l</given-names></name><name><surname>Zhang</surname><given-names>X</given-names></name><name><surname>Deng</surname><given-names>S-q</given-names></name><name><surname>Peng</surname><given-names>B</given-names></name></person-group><article-title>In silico screening of Chinese herbal medicines with the potential to directly inhibit 2019 novel coronavirus</article-title><source> Journal of Integrative Medicine</source><year>2020</year><volume>18</volume><issue>2</issue><fpage>152</fpage><lpage>8</lpage><pub-id pub-id-type="pmid">32113846</pub-id></element-citation></ref><ref id="B22"><label>22</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wu</surname><given-names>F</given-names></name><name><surname>Zhao</surname><given-names>S</given-names></name><name><surname>Yu</surname><given-names>B</given-names></name><name><surname>Chen</surname><given-names>Y-M</given-names></name><name><surname>Wang</surname><given-names>W</given-names></name><name><surname>Song</surname><given-names>Z-G</given-names></name><etal/></person-group><article-title>A new coronavirus associated with human respiratory disease in China</article-title><source> Nature</source><year>2020</year><volume>579</volume><issue>7798</issue><fpage>265</fpage><lpage>9</lpage><pub-id pub-id-type="pmid">32015508</pub-id></element-citation></ref><ref id="B23"><label>23</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Menachery</surname><given-names>VD</given-names></name><name><surname>Yount</surname><given-names>BL</given-names></name><name><surname>Debbink</surname><given-names>K</given-names></name><name><surname>Agnihothram</surname><given-names>S</given-names></name><name><surname>Gralinski</surname><given-names>LE</given-names></name><name><surname>Plante</surname><given-names>JA</given-names></name><etal/></person-group><article-title>A SARS-like cluster of circulating bat coronaviruses shows potential for human emergence</article-title><source> Nature Medicine</source><year>2015</year><volume>21</volume><issue>12</issue><fpage>1508</fpage><lpage>13</lpage></element-citation></ref><ref id="B24"><label>24</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lu</surname><given-names>R</given-names></name><name><surname>Zhao</surname><given-names>X</given-names></name><name><surname>Li</surname><given-names>J</given-names></name><name><surname>Niu</surname><given-names>P</given-names></name><name><surname>Yang</surname><given-names>B</given-names></name><name><surname>Wu</surname><given-names>H</given-names></name><etal/></person-group><article-title>Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding</article-title><source> The Lancet</source><year>2020</year><volume>395</volume><issue>10224</issue><fpage>565</fpage><lpage>74</lpage></element-citation></ref><ref id="B25"><label>25</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Loewe</surname><given-names>L</given-names></name><name><surname>Hill</surname><given-names>WG</given-names></name></person-group><article-title>The population genetics of mutations: good, bad and indifferent</article-title><source> Philosophical Transactions of the Royal Society B: Biological Sciences</source><year>2010</year><volume>365</volume><issue>1544</issue><fpage>1153</fpage><lpage>67</lpage></element-citation></ref><ref id="B26"><label>26</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yang</surname><given-names>Y</given-names></name><name><surname>Peng</surname><given-names>F</given-names></name><name><surname>Wang</surname><given-names>R</given-names></name><name><surname>Guan</surname><given-names>K</given-names></name><name><surname>Jiang</surname><given-names>T</given-names></name><name><surname>Xu</surname><given-names>G</given-names></name><etal/></person-group><article-title>The deadly coronaviruses: The 2003 SARS pandemic and the 2020 novel coronavirus epidemic in China</article-title><source> Journal of Autoimmunity</source><year>2020</year><volume>109</volume><fpage>102434</fpage><pub-id pub-id-type="pmid">32143990</pub-id></element-citation></ref><ref id="B27"><label>27</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rojas</surname><given-names>M</given-names></name><name><surname>Rodriguez</surname><given-names>Y</given-names></name><name><surname>Monsalve</surname><given-names>DM</given-names></name><name><surname>Acosta-Ampudia</surname><given-names>Y</given-names></name><name><surname>Camacho</surname><given-names>B</given-names></name><name><surname>Gallo</surname><given-names>JE</given-names></name><etal/></person-group><article-title>Convalescent plasma in Covid-19: Possible mechanisms of action</article-title><source> Autoimmunity Reviews</source><volume>2020</volume><fpage>102554</fpage></element-citation></ref><ref id="B28"><label>28</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kowalik</surname><given-names>MM</given-names></name><name><surname>Trzonkowski</surname><given-names>P</given-names></name><name><surname>&#x00141;asi&#x00144;ska-Kowara</surname><given-names>M</given-names></name><name><surname>Mital</surname><given-names>A</given-names></name><name><surname>Smiatacz</surname><given-names>T</given-names></name><name><surname>Jaguszewski</surname><given-names>M</given-names></name></person-group><article-title>COVID-19 &#x02014; toward a comprehensive understanding of the disease</article-title><source> Cardiology Journal</source><year>2020</year></element-citation></ref><ref id="B29"><label>29</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wurtzer</surname><given-names>S</given-names></name><name><surname>Marechal</surname><given-names>V</given-names></name><name><surname>Mouchel</surname><given-names>J-M</given-names></name><name><surname>Moulin</surname><given-names>L</given-names></name></person-group><article-title>Time course quantitative detection of SARS-CoV-2 in Parisian wastewaters correlates with COVID-19 confirmed cases</article-title><source> medRxiv</source><volume>2020</volume><fpage>2020.04.12.20062679</fpage><lpage>2020</lpage></element-citation></ref><ref id="B30"><label>30</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhou</surname><given-names>P</given-names></name><name><surname>Fan</surname><given-names>H</given-names></name><name><surname>Lan</surname><given-names>T</given-names></name><name><surname>Yang</surname><given-names>X-L</given-names></name><name><surname>Shi</surname><given-names>W-F</given-names></name><name><surname>Zhang</surname><given-names>W</given-names></name><etal/></person-group><article-title>Fatal swine acute diarrhoea syndrome caused by an HKU2-related coronavirus of bat origin</article-title><source> Nature</source><year>2018</year><volume>556</volume><issue>7700</issue><fpage>255</fpage><lpage>8</lpage><pub-id pub-id-type="pmid">29618817</pub-id></element-citation></ref><ref id="B31"><label>31</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brown</surname><given-names>JD</given-names></name></person-group><article-title>Cannabidiol as prophylaxis for SARS-CoV-2 and COVID-19? Unfounded claims versus potential risks of medications during the pandemic</article-title><source> Research in social &#x00026; administrative pharmacy: RSAP</source><year>2020</year></element-citation></ref><ref id="B32"><label>32</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vidondo</surname><given-names>B</given-names></name></person-group><article-title>Amplification of the basic reproduction number in cattle farm networks</article-title><source> PLOS ONE</source><year>2018</year><volume>13</volume><issue>4</issue><fpage>e0191257</fpage><lpage>e</lpage><pub-id pub-id-type="pmid">29672512</pub-id></element-citation></ref><ref id="B33"><label>33</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>Y</given-names></name><name><surname>Gayle</surname><given-names>AA</given-names></name><name><surname>Wilder-Smith</surname><given-names>A</given-names></name><name><surname>Rockl&#x000f6;v</surname><given-names>J</given-names></name></person-group><article-title>The reproductive number of COVID-19 is higher compared to SARS coronavirus</article-title><source> Journal of Travel Medicine</source><year>2020</year><volume>27</volume><issue>2</issue></element-citation></ref><ref id="B34"><label>34</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wu</surname><given-names>JCea</given-names></name></person-group><article-title>The current treatment landscape of irritable bowel syndrome in adults in Hong Kong: consensus statements</article-title><source> Hong Kong Medical Journal</source><year>2017</year><fpage>641</fpage><lpage>7</lpage><pub-id pub-id-type="pmid">29226832</pub-id></element-citation></ref><ref id="B35"><label>35</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hong</surname><given-names>Kong Department of Health</given-names></name></person-group><article-title>Outbreak of Severe Acute Respiratory Syndrome (SARS) at Amoy Gardens, Kowloon Bay </article-title><source>Hong Kong Main Findings of the Investigation</source><year>1993</year></element-citation></ref><ref id="B36"><label>36</label><element-citation publication-type="journal"><article-title>Legislative Council Select Committee to inquire into the handling of the Severe Acute Respiratory Syndrome outbreak by the Government</article-title><source>the Hospital Authority of Hong Kong</source><year>2003</year></element-citation></ref><ref id="B37"><label>37</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>McKinney</surname><given-names>Kr GYYLTG</given-names></name></person-group><article-title>Environmental transmission of SARS at Amoy Gardens</article-title><source> J Environ Health</source><year>2006</year><volume>68</volume><issue>9</issue><fpage>26</fpage><lpage>30</lpage></element-citation></ref><ref id="B38"><label>38</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Al-Tawfiq</surname><given-names>JA</given-names></name><name><surname>Rodriguez-Morales</surname><given-names>AJ</given-names></name></person-group><article-title>SARS-CoV-2 (COVID-19)</article-title><source> Journal of Hospital Infection</source><year>2020</year><volume>105</volume><issue>2</issue><fpage>111</fpage><lpage>2</lpage><pub-id pub-id-type="pmid">32277963</pub-id></element-citation></ref><ref id="B39"><label>39</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Forster</surname><given-names>P</given-names></name><name><surname>Forster</surname><given-names>L</given-names></name><name><surname>Renfrew</surname><given-names>C</given-names></name><name><surname>Forster</surname><given-names>M</given-names></name></person-group><article-title>Phylogenetic network analysis of SARS-CoV-2 genomes</article-title><source> Proceedings of the National Academy of Sciences</source><year>2020</year><volume>117</volume><issue>17</issue><fpage>9241</fpage><lpage>3</lpage></element-citation></ref><ref id="B40"><label>40</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rasche</surname><given-names>A</given-names></name><name><surname>Sander</surname><given-names>A-L</given-names></name><name><surname>Corman</surname><given-names>VM</given-names></name><name><surname>Drexler</surname><given-names>JF</given-names></name></person-group><article-title>Evolutionary biology of human hepatitis viruses</article-title><source> Journal of Hepatology</source><year>2019</year><volume>70</volume><issue>3</issue><fpage>501</fpage><lpage>20</lpage><pub-id pub-id-type="pmid">30472320</pub-id></element-citation></ref><ref id="B41"><label>41</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Taguchi</surname><given-names>F</given-names></name></person-group><article-title>Coronavirus Receptors</article-title><source> Boston, MA: Springer US;</source><year>2005</year><fpage> 821</fpage><lpage>31</lpage></element-citation></ref><ref id="B42"><label>42</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wei</surname><given-names>WE</given-names></name><name><surname>Li</surname><given-names>Z</given-names></name><name><surname>Chiew</surname><given-names>CJ</given-names></name><name><surname>Yong</surname><given-names>SE</given-names></name><name><surname>Toh</surname><given-names>MP</given-names></name><name><surname>Lee</surname><given-names>VJ</given-names></name></person-group><article-title>Presymptomatic Transmission of SARS-CoV-2 &#x02014; Singapore, January 23&#x02013;March 16, 2020</article-title><source> MMWR Morbidity and Mortality Weekly Report</source><year>2020</year><volume>69</volume><issue>14</issue><fpage>411</fpage><lpage>5</lpage><pub-id pub-id-type="pmid">32271722</pub-id></element-citation></ref><ref id="B43"><label>43</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gu</surname><given-names>Y</given-names></name></person-group><article-title>Pandemic (H1N1) 2009 Transmission during Presymptomatic Phase, Japan</article-title><source> Emerging Infectious Diseases</source><year>2011</year><volume>17</volume><issue>9</issue><fpage>1737</fpage><lpage>9</lpage><pub-id pub-id-type="pmid">21888808</pub-id></element-citation></ref><ref id="B44"><label>44</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Thompson</surname><given-names>RN</given-names></name><name><surname>Gilligan</surname><given-names>CA</given-names></name><name><surname>Cunniffe</surname><given-names>NJ</given-names></name></person-group><article-title>Detecting Presymptomatic Infection Is Necessary to Forecast Major Epidemics in the Earliest Stages of Infectious Disease Outbreaks</article-title><source> PLOS Computational Biology</source><year>2016</year><volume>12</volume><issue>4</issue><fpage>e1004836</fpage><lpage>e</lpage><pub-id pub-id-type="pmid">27046030</pub-id></element-citation></ref><ref id="B45"><label>45</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rockl&#x000f6;v</surname><given-names>J</given-names></name><name><surname>Sj&#x000f6;din</surname><given-names>H</given-names></name><name><surname>Wilder-Smith</surname><given-names>A</given-names></name></person-group><article-title>COVID-19 outbreak on the Diamond Princess cruise ship: estimating the epidemic potential and effectiveness of public health countermeasures</article-title><source> Journal of Travel Medicine</source><year>2020</year></element-citation></ref><ref id="B46"><label>46</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>C</given-names></name><name><surname>Liu</surname><given-names>L</given-names></name><name><surname>Hao</surname><given-names>X</given-names></name><name><surname>Guo</surname><given-names>H</given-names></name><name><surname>Wang</surname><given-names>Q</given-names></name><name><surname>Huang</surname><given-names>J</given-names></name><etal/></person-group><article-title>Evolving Epidemiology and Impact of Non-pharmaceutical Interventions on the Outbreak of Coronavirus Disease 2019 in Wuhan, China</article-title><source> medRxiv</source><year>2020</year><fpage>2020:2020.03.03.20030593</fpage></element-citation></ref><ref id="B47"><label>47</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gao</surname><given-names>Y</given-names></name><name><surname>Yan</surname><given-names>L</given-names></name><name><surname>Huang</surname><given-names>Y</given-names></name><name><surname>Liu</surname><given-names>F</given-names></name><name><surname>Zhao</surname><given-names>Y</given-names></name><name><surname>Cao</surname><given-names>L</given-names></name><etal/></person-group><article-title>Structure of the RNA-dependent RNA polymerase from COVID-19 virus</article-title><source> Science</source><volume>2020</volume><fpage>eabb7498</fpage><lpage>eabb</lpage></element-citation></ref><ref id="B48"><label>48</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Goldhill</surname><given-names>DH</given-names></name><name><surname>te</surname><given-names>Velthuis AJW</given-names></name><name><surname>Fletcher</surname><given-names>RA</given-names></name><name><surname>Langat</surname><given-names>P</given-names></name><name><surname>Zambon</surname><given-names>M</given-names></name><name><surname>Lackenby</surname><given-names>A</given-names></name><etal/></person-group><article-title>The mechanism of resistance to favipiravir in influenza</article-title><source> Proceedings of the National Academy of Sciences</source><year>2018</year><volume>115</volume><issue>45</issue><fpage>11613</fpage><lpage>8</lpage></element-citation></ref><ref id="B49"><label>49</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Forni</surname><given-names>D</given-names></name><name><surname>Filippi</surname><given-names>G</given-names></name><name><surname>Cagliani</surname><given-names>R</given-names></name><name><surname>De</surname><given-names>Gioia L</given-names></name><name><surname>Pozzoli</surname><given-names>U</given-names></name><name><surname>Al-Daghri</surname><given-names>N</given-names></name><etal/></person-group><article-title>The heptad repeat region is a major selection target in MERS-CoV and related coronaviruses</article-title><source> Scientific Reports</source><year>2015</year><volume>5</volume><issue>1</issue><fpage>14480</fpage><pub-id pub-id-type="pmid">26404138</pub-id></element-citation></ref><ref id="B50"><label>50</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tang</surname><given-names>H</given-names></name><name><surname>Liu</surname><given-names>Y</given-names></name><name><surname>Huang</surname><given-names>G</given-names></name></person-group><article-title>Current Status and Development Strategy for Community-Supported Agriculture (CSA) in China</article-title><source> Sustainability</source><year>2019</year><volume>11</volume><issue>11</issue><fpage>3008</fpage></element-citation></ref><ref id="B51"><label>51</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chowell</surname><given-names>Gea</given-names></name></person-group><article-title>Transmission characteristics of MERS and SARS in the healthcare setting: a comparative study</article-title><source> BMC Medicine</source><year>2015</year><volume>13</volume><issue>1</issue><fpage>210</fpage><pub-id pub-id-type="pmid">26336062</pub-id></element-citation></ref><ref id="B52"><label>52</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gormley</surname><given-names>Mea</given-names></name></person-group><article-title>Pathogen cross-transmission via building sanitary plumbing systems in a full scale pilot test-rig</article-title><source> PLOS ONE</source><year>2017</year><volume>12</volume><issue>2</issue><fpage>e0171556</fpage><pub-id pub-id-type="pmid">28187135</pub-id></element-citation></ref><ref id="B53"><label>53</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lau</surname><given-names>Y-L</given-names></name></person-group><article-title>SARS: future research and vaccine</article-title><source> Paediatric Respiratory Reviews,</source><year>2004</year><volume>5</volume><issue>4</issue><fpage>300</fpage><lpage>3</lpage><pub-id pub-id-type="pmid">15531254</pub-id></element-citation></ref><ref id="B54"><label>54</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>Yea</given-names></name></person-group><article-title>Predicting super spreading events during the 2003 severe acute respiratory syndrome epidemics in Hong Kong and Singapore</article-title><source> American journal of epidemiology,</source><year>2004</year><volume>160</volume><issue>8</issue><fpage>719</fpage><lpage>28</lpage><pub-id pub-id-type="pmid">15466494</pub-id></element-citation></ref><ref id="B55"><label>55</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shaw</surname><given-names>K</given-names></name></person-group><article-title>The 2003 SARS outbreak and its impact on infection control practices</article-title><source> Public Health</source><year>2006</year><volume>120</volume><issue>1</issue><fpage>8</fpage><lpage>14</lpage></element-citation></ref><ref id="B56"><label>56</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cave</surname><given-names>E</given-names></name></person-group><article-title>COVID-19 Super-spreaders: Definitional Quandaries and Implications</article-title><source> Asian Bioethics Review</source><year>2020</year><volume>12</volume><issue>2</issue><fpage>235</fpage><lpage>42</lpage></element-citation></ref><ref id="B57"><label>57</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Xu</surname><given-names>X-Kea</given-names></name></person-group><article-title>Reconstruction of Transmission Pairs for Novel Coronavirus Disease 2019 (COVID-19) in Mainland China: Estimation of Superspreading Events, Serial Interval, and Hazard of Infection</article-title><source> Clinical Infectious Diseases</source><year>2020</year></element-citation></ref><ref id="B58"><label>58</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kwok</surname><given-names>KOea</given-names></name></person-group><article-title>Inferring super-spreading from transmission clusters of COVID-19 in Hong Kong, Japan, and Singapore</article-title><source> Journal of Hospital Infection</source><year>2020</year><volume>105</volume><issue>4</issue><fpage>682</fpage><lpage>5</lpage><pub-id pub-id-type="pmid">32446721</pub-id></element-citation></ref><ref id="B59"><label>59</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chau</surname><given-names>T-N</given-names></name><name><surname>Lee</surname><given-names>K-C</given-names></name><name><surname>Yao</surname><given-names>H</given-names></name><name><surname>Tsang</surname><given-names>T-Y</given-names></name><name><surname>Chow</surname><given-names>T-C</given-names></name><name><surname>Yeung</surname><given-names>Y-C</given-names></name><etal/></person-group><article-title>SARS-associated viral hepatitis caused by a novel coronavirus: Report of three cases</article-title><source> Hepatology</source><year>2004</year><volume>39</volume><issue>2</issue><fpage>302</fpage><lpage>10</lpage><pub-id pub-id-type="pmid">14767982</pub-id></element-citation></ref><ref id="B60"><label>60</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tu</surname><given-names>Y-F</given-names></name><name><surname>Chien</surname><given-names>C-S</given-names></name><name><surname>Yarmishyn</surname><given-names>AA</given-names></name><name><surname>Lin</surname><given-names>Y-Y</given-names></name><name><surname>Luo</surname><given-names>Y-H</given-names></name><name><surname>Lin</surname><given-names>Y-T</given-names></name><etal/></person-group><article-title>A Review of SARS-CoV-2 and the Ongoing Clinical Trials</article-title><source> International Journal of Molecular Sciences</source><year>2020</year><volume>21</volume><issue>7</issue><fpage>2657</fpage></element-citation></ref><ref id="B61"><label>61</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Luk</surname><given-names>HKH</given-names></name><name><surname>Li</surname><given-names>X</given-names></name><name><surname>Fung</surname><given-names>J</given-names></name><name><surname>Lau</surname><given-names>SKP</given-names></name><name><surname>Woo</surname><given-names>PCY</given-names></name></person-group><article-title>Molecular epidemiology, evolution and phylogeny of SARS coronavirus</article-title><source> Infection, Genetics and Evolution</source><year>2019</year><volume>71</volume><fpage>21</fpage><lpage>30</lpage></element-citation></ref><ref id="B62"><label>62</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>Y-H</given-names></name><name><surname>Hu</surname><given-names>C-Y</given-names></name><name><surname>Wu</surname><given-names>N-P</given-names></name><name><surname>Yao</surname><given-names>H-P</given-names></name><name><surname>Li</surname><given-names>L-J</given-names></name></person-group><article-title>Molecular Characteristics, Functions, and Related Pathogenicity of MERS-CoV Proteins</article-title><source> Engineering</source><year>2019</year><volume>5</volume><issue>5</issue><fpage>940</fpage><lpage>7</lpage><pub-id pub-id-type="pmid">32288963</pub-id></element-citation></ref><ref id="B63"><label>63</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Weiss</surname><given-names>SR</given-names></name><name><surname>Navas-Martin</surname><given-names>S</given-names></name></person-group><article-title>Coronavirus Pathogenesis and the Emerging Pathogen Severe Acute Respiratory Syndrome Coronavirus</article-title><source> Microbiology and Molecular Biology Reviews</source><year>2005</year><volume>69</volume><issue>4</issue><fpage>635</fpage><lpage>64</lpage><pub-id pub-id-type="pmid">16339739</pub-id></element-citation></ref><ref id="B64"><label>64</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mousavizadeh</surname><given-names>L</given-names></name><name><surname>Ghasemi</surname><given-names>S</given-names></name></person-group><article-title>Genotype and phenotype of COVID-19: Their roles in pathogenesis</article-title><source> Journal of Microbiology, Immunology and Infection</source><year>2020</year></element-citation></ref><ref id="B65"><label>65</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hu</surname><given-names>B</given-names></name><name><surname>Ge</surname><given-names>X</given-names></name><name><surname>Wang</surname><given-names>L-F</given-names></name><name><surname>Shi</surname><given-names>Z</given-names></name></person-group><article-title>Bat origin of human coronaviruses</article-title><source> Virology Journal</source><year>2015</year><volume>12</volume><issue>1</issue><fpage>221</fpage><pub-id pub-id-type="pmid">26689940</pub-id></element-citation></ref><ref id="B66"><label>66</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Knobler</surname><given-names>S MALS</given-names></name></person-group><source>The impact of SARS epidemic</source><year>2004</year><publisher-loc> Washington, D.C</publisher-loc><publisher-name>National Academies Press</publisher-name></element-citation></ref><ref id="B67"><label>67</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Lee</surname><given-names>Jw MWJ</given-names></name></person-group><source>Estimating the global economic costs of SARS</source><year>2004</year><publisher-loc>Washington, D.C</publisher-loc><publisher-name>National Academies Press</publisher-name></element-citation></ref><ref id="B68"><label>68</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kingston</surname><given-names>D</given-names></name></person-group><article-title>Memorandum on the infections hazards of the common communion cup with especial reference to aids</article-title><source> European Journal of Epidemiology</source><year>1988</year><volume>4</volume><issue>2</issue><fpage>164</fpage><lpage>70</lpage><pub-id pub-id-type="pmid">3402575</pub-id></element-citation></ref><ref id="B69"><label>69</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gill</surname><given-names>ON</given-names></name></person-group><article-title>The hazard of infection from the shared communion cup</article-title><source> Journal of Infection</source><year>1988</year><volume>16</volume><issue>1</issue><fpage>3</fpage><lpage>23</lpage><pub-id pub-id-type="pmid">3284951</pub-id></element-citation></ref><ref id="B70"><label>70</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pellerin</surname><given-names>J</given-names></name><name><surname>Edmond</surname><given-names>MB</given-names></name></person-group><article-title>Infections associated with religious rituals</article-title><source> International Journal of Infectious Diseases</source><year>2013</year><volume>17</volume><issue>11</issue><fpage>e945</fpage><lpage>e8</lpage><pub-id pub-id-type="pmid">23791225</pub-id></element-citation></ref><ref id="B71"><label>71</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Corstjens</surname><given-names>PLAM</given-names></name><name><surname>Abrams</surname><given-names>WR</given-names></name><name><surname>Malamud</surname><given-names>D</given-names></name></person-group><article-title>Saliva and viral infections</article-title><source> Periodontology</source><year>2000</year><volume>70</volume><issue>1</issue><fpage>93</fpage><lpage>110</lpage></element-citation></ref><ref id="B72"><label>72</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pintilie</surname><given-names>H</given-names></name><name><surname>Brook</surname><given-names>G</given-names></name></person-group><article-title>Commentary: A review of risk of hepatitis B and C transmission through biting or spitting</article-title><source> Journal of Viral Hepatitis</source><year>2018</year><volume>25</volume><issue>12</issue><fpage>1423</fpage><lpage>8</lpage><pub-id pub-id-type="pmid">30047616</pub-id></element-citation></ref><ref id="B73"><label>73</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Peng</surname><given-names>X</given-names></name><name><surname>Xu</surname><given-names>X</given-names></name><name><surname>Li</surname><given-names>Y</given-names></name><name><surname>Cheng</surname><given-names>L</given-names></name><name><surname>Zhou</surname><given-names>X</given-names></name><name><surname>Ren</surname><given-names>B</given-names></name></person-group><article-title>Transmission routes of 2019-nCoV and controls in dental practice</article-title><source> International Journal of Oral Science</source><year>2020</year><volume>12</volume><issue>1</issue><fpage>9</fpage><pub-id pub-id-type="pmid">32127517</pub-id></element-citation></ref><ref id="B74"><label>74</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Xu</surname><given-names>R</given-names></name><name><surname>Cui</surname><given-names>B</given-names></name><name><surname>Duan</surname><given-names>X</given-names></name><name><surname>Zhang</surname><given-names>P</given-names></name><name><surname>Zhou</surname><given-names>X</given-names></name><name><surname>Yuan</surname><given-names>Q</given-names></name></person-group><article-title>Saliva: potential diagnostic value and transmission of 2019-nCoV</article-title><source> International Journal of Oral Science</source><year>2020</year><volume>12</volume><issue>1</issue><fpage>11</fpage><pub-id pub-id-type="pmid">32300101</pub-id></element-citation></ref><ref id="B75"><label>75</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kidd-Ljunggren</surname><given-names>K</given-names></name><name><surname>Holmberg</surname><given-names>A</given-names></name><name><surname>Bl&#x000e4;ckberg</surname><given-names>J</given-names></name><name><surname>Lindqvist</surname><given-names>B</given-names></name></person-group><article-title>High levels of hepatitis B virus DNA in body fluids from chronic carriers</article-title><source> Journal of Hospital Infection</source><year>2006</year><volume>64</volume><issue>4</issue><fpage>352</fpage><lpage>7</lpage><pub-id pub-id-type="pmid">17046105</pub-id></element-citation></ref><ref id="B76"><label>76</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kountouras</surname><given-names>J TEMSSCTGPA</given-names></name><etal/></person-group><article-title>Experience of entecavir administration in patients with chronic hepatitis B</article-title><source> Annals of gastroenterology</source><year>2010</year><volume>23</volume><comment>Suppl)(57 (in Greek))</comment></element-citation></ref><ref id="B77"><label>77</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>AminJafari</surname><given-names>A</given-names></name><name><surname>Ghasemi</surname><given-names>S</given-names></name></person-group><article-title>The possible of immunotherapy for COVID-19: A systematic review</article-title><source> International Immunopharmacology</source><year>2020</year><volume>83</volume><fpage>106455</fpage><pub-id pub-id-type="pmid">32272396</pub-id></element-citation></ref><ref id="B78"><label>78</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Dimmock</surname><given-names>K ENJLAJ</given-names></name></person-group><source>Introduction to modern virology</source><publisher-loc>New York, NY2007</publisher-loc><publisher-name>Blackwell</publisher-name><fpage>65</fpage></element-citation></ref><ref id="B79"><label>79</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Saif</surname><given-names>LJ</given-names></name></person-group><article-title>Animal coronavirus vaccines: Lessons for SARS</article-title><source> Developments in Biologicals</source><year>2005</year><volume>119</volume><fpage>129</fpage><lpage>40</lpage></element-citation></ref><ref id="B80"><label>80</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jimenez-Guarde&#x000f1;o</surname><given-names>JM</given-names></name><name><surname>Regla-Nava</surname><given-names>JA</given-names></name><name><surname>Nieto-Torres</surname><given-names>JL</given-names></name><name><surname>DeDiego</surname><given-names>ML</given-names></name><name><surname>Casta&#x000f1;o-Rodriguez</surname><given-names>C</given-names></name><name><surname>Fernandez-Delgado</surname><given-names>R</given-names></name><etal/></person-group><article-title>Identification of the Mechanisms Causing Reversion to Virulence in an Attenuated SARS-CoV for the Design of a Genetically Stable Vaccine</article-title><source> PLOS Pathogens</source><year>2015</year><volume>11</volume><issue>10</issue><fpage>e1005215</fpage><lpage>e</lpage><pub-id pub-id-type="pmid">26513244</pub-id></element-citation></ref><ref id="B81"><label>81</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bolles</surname><given-names>M</given-names></name><name><surname>Deming</surname><given-names>D</given-names></name><name><surname>Long</surname><given-names>K</given-names></name><name><surname>Agnihothram</surname><given-names>S</given-names></name><name><surname>Whitmore</surname><given-names>A</given-names></name><name><surname>Ferris</surname><given-names>M</given-names></name><etal/></person-group><article-title>A Double-Inactivated Severe Acute Respiratory Syndrome Coronavirus Vaccine Provides Incomplete Protection in Mice and Induces Increased Eosinophilic Proinflammatory Pulmonary Response upon Challenge</article-title><source> Journal of Virology</source><year>2011</year><volume>85</volume><issue>23</issue><fpage>12201</fpage><lpage>15</lpage><pub-id pub-id-type="pmid">21937658</pub-id></element-citation></ref><ref id="B82"><label>82</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Peeples</surname><given-names>L</given-names></name></person-group><article-title>News Feature: Avoiding pitfalls in the pursuit of a COVID-19 vaccine</article-title><source> Proceedings of the National Academy of Sciences</source><year>2020</year><volume>117</volume><issue>15</issue><fpage>8218</fpage><lpage>21</lpage></element-citation></ref><ref id="B83"><label>83</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sheahan</surname><given-names>T</given-names></name><name><surname>Whitmore</surname><given-names>A</given-names></name><name><surname>Long</surname><given-names>K</given-names></name><name><surname>Ferris</surname><given-names>M</given-names></name><name><surname>Rockx</surname><given-names>B</given-names></name><name><surname>Funkhouser</surname><given-names>W</given-names></name><etal/></person-group><article-title>Successful Vaccination Strategies That Protect Aged Mice from Lethal Challenge from Influenza Virus and Heterologous Severe Acute Respiratory Syndrome Coronavirus</article-title><source> Journal of Virology</source><year>2011</year><volume>85</volume><issue>1</issue><fpage>217</fpage><lpage>30</lpage><pub-id pub-id-type="pmid">20980507</pub-id></element-citation></ref><ref id="B84"><label>84</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Spruth</surname><given-names>M</given-names></name><name><surname>Kistner</surname><given-names>O</given-names></name><name><surname>Savidis-Dacho</surname><given-names>H</given-names></name><name><surname>Hitter</surname><given-names>E</given-names></name><name><surname>Crowe</surname><given-names>B</given-names></name><name><surname>Gerencer</surname><given-names>M</given-names></name><etal/></person-group><article-title>A double-inactivated whole virus candidate SARS coronavirus vaccine stimulates neutralising and protective antibody responses</article-title><source> Vaccine</source><year>2006</year><volume>24</volume><issue>5</issue><fpage>652</fpage><lpage>61</lpage><pub-id pub-id-type="pmid">16214268</pub-id></element-citation></ref><ref id="B85"><label>85</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yap</surname><given-names>FHY</given-names></name><name><surname>Gomersall</surname><given-names>CD</given-names></name><name><surname>Fung</surname><given-names>KSC</given-names></name><name><surname>Ho</surname><given-names>PL</given-names></name><name><surname>Ho</surname><given-names>OM</given-names></name><name><surname>Lam</surname><given-names>PKN</given-names></name><etal/></person-group><article-title>Increase in Methicillin-Resistant Staphylococcus aureus Acquisition Rate and Change in Pathogen Pattern Associated with an Outbreak of Severe Acute Respiratory Syndrome</article-title><source> Clinical Infectious Diseases</source><year>2004</year><volume>39</volume><issue>4</issue><fpage>511</fpage><lpage>6</lpage><pub-id pub-id-type="pmid">15356814</pub-id></element-citation></ref><ref id="B86"><label>86</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hotez</surname><given-names>PJ</given-names></name><name><surname>Bottazzi</surname><given-names>ME</given-names></name><name><surname>Corry</surname><given-names>DB</given-names></name></person-group><article-title>The potential role of Th17 immune responses in coronavirus immunopathology and vaccine-induced immune enhancement</article-title><source> Microbes and Infection</source><year>2020</year></element-citation></ref><ref id="B87"><label>87</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wu</surname><given-names>D</given-names></name><name><surname>Yang</surname><given-names>XO</given-names></name></person-group><article-title>TH17 responses in cytokine storm of COVID-19: An emerging target of JAK2 inhibitor Fedratinib</article-title><source> Journal of Microbiology, Immunology and Infection</source><year>2020</year></element-citation></ref><ref id="B88"><label>88</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chow</surname><given-names>SCS</given-names></name></person-group><article-title>Specific epitopes of the structural and hypothetical proteins elicit variable humoral responses in SARS patients</article-title><source> Journal of Clinical Pathology</source><year>2006</year><volume>59</volume><issue>5</issue><fpage>468</fpage><lpage>76</lpage><pub-id pub-id-type="pmid">16461566</pub-id></element-citation></ref><ref id="B89"><label>89</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Melsew</surname><given-names>YA</given-names></name><name><surname>Gambhir</surname><given-names>M</given-names></name><name><surname>Cheng</surname><given-names>AC</given-names></name><name><surname>McBryde</surname><given-names>ES</given-names></name><name><surname>Denholm</surname><given-names>JT</given-names></name><name><surname>Tay</surname><given-names>EL</given-names></name><etal/></person-group><article-title>The role of super-spreading events in Mycobacterium tuberculosis transmission: evidence from contact tracing</article-title><source> BMC Infectious Diseases</source><year>2019</year><volume>19</volume><issue>1</issue><fpage>244</fpage><pub-id pub-id-type="pmid">30866840</pub-id></element-citation></ref><ref id="B90"><label>90</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Drobeniuc</surname><given-names>J</given-names></name><name><surname>Greene-Montfort</surname><given-names>T</given-names></name><name><surname>Le</surname><given-names>N-T</given-names></name><name><surname>Mixson-Hayden</surname><given-names>TR</given-names></name><name><surname>Ganova-Raeva</surname><given-names>L</given-names></name><name><surname>Dong</surname><given-names>C</given-names></name><etal/></person-group><article-title>Laboratory-based Surveillance for Hepatitis E Virus Infection, United States, 2005&#x02013;2012</article-title><source> Emerging Infectious Diseases</source><year>2013</year><volume>19</volume><issue>2</issue><fpage>218</fpage><lpage>22</lpage><pub-id pub-id-type="pmid">23347695</pub-id></element-citation></ref><ref id="B91"><label>91</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Komas</surname><given-names>NP</given-names></name><name><surname>Ghosh</surname><given-names>S</given-names></name><name><surname>Abdou-Chekaraou</surname><given-names>M</given-names></name><name><surname>Pradat</surname><given-names>P</given-names></name><name><surname>Al</surname><given-names>Hawajri N</given-names></name><name><surname>Manirakiza</surname><given-names>A</given-names></name><etal/></person-group><article-title>Hepatitis B and hepatitis D virus infections in the Central African Republic, twenty-five years after a fulminant hepatitis outbreak, indicate continuing spread in asymptomatic young adults</article-title><source> PLOS Neglected Tropical Diseases</source><year>2018</year><volume>12</volume><issue>4</issue><fpage>e0006377</fpage><lpage>e</lpage><pub-id pub-id-type="pmid">29698488</pub-id></element-citation></ref><ref id="B92"><label>92</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chan</surname><given-names>C-Mea</given-names></name></person-group><article-title>Carcinoembryonic Antigen-Related Cell Adhesion Molecule 5 Is an Important Surface Attachment Factor That Facilitates Entry of Middle East Respiratory Syndrome Coronavirus</article-title><source> Journal of Virology Edited by S Perlman</source><year>2016</year><volume>90</volume><issue>20</issue><fpage>9114</fpage><lpage>27</lpage></element-citation></ref><ref id="B93"><label>93</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mothes</surname><given-names>Wea</given-names></name></person-group><article-title>Virus Cell-to-Cell Transmission</article-title><source> Journal of Virology</source><year>2010</year><volume>84</volume><issue>17</issue><fpage>8360</fpage><lpage>8</lpage><pub-id pub-id-type="pmid">20375157</pub-id></element-citation></ref><ref id="B94"><label>94</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Peiris</surname><given-names>Jea</given-names></name></person-group><article-title>Clinical progression and viral load in a community outbreak of coronavirus-associated SARS pneumonia: a prospective study&#x02019;</article-title><source> The Lancet</source><year>2003</year><volume>361</volume><issue>9371</issue><fpage>1767</fpage><lpage>72</lpage></element-citation></ref><ref id="B95"><label>95</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Spiegel</surname><given-names>Mea</given-names></name></person-group><article-title>Interaction of severe acute respiratory syndrome-associated coronavirus with dendritic cells</article-title><source> The Journal of general virology</source><year>2006</year><volume>87</volume><issue>7</issue><fpage>1953</fpage><lpage>60</lpage><pub-id pub-id-type="pmid">16760397</pub-id></element-citation></ref><ref id="B96"><label>96</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>MIC LS-C</given-names></name><name><surname>Leong</surname><given-names>H-N</given-names></name><name><surname>Leo</surname><given-names>Y-S</given-names></name></person-group><article-title>Understanding the super-spreading events of SARS in Singapore</article-title><source> Ann Acad Med Singapore</source><year>2006</year><volume>35</volume><fpage>390</fpage><lpage>4</lpage><pub-id pub-id-type="pmid">16865188</pub-id></element-citation></ref><ref id="B97"><label>97</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sung</surname><given-names>JJY YI</given-names></name><name><surname>Zhong</surname><given-names>NS</given-names></name><name><surname>Tsoi</surname><given-names>K</given-names></name></person-group><article-title>Super-spreading events of SARS in a hospital setting: who, when, and why?</article-title><source> Hong Kong Med J = Xianggang yi xue za zhi </source><year>2009</year><volume>15</volume><issue>Suppl 8</issue><fpage>29</fpage><lpage>33</lpage><pub-id pub-id-type="pmid">20393210</pub-id></element-citation></ref><ref id="B98"><label>98</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stein</surname><given-names>RA</given-names></name></person-group><article-title>Super-spreaders in infectious diseases</article-title><source> International Journal of Infectious Diseases</source><year>2011</year><volume>15</volume><issue>8</issue><fpage>e510</fpage><lpage>e3</lpage><pub-id pub-id-type="pmid">21737332</pub-id></element-citation></ref></ref-list></back></article>